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This project aimed to enhance our understanding of the signal transduction 
pathways which were regulated by neurotrophic factors such as nerve growth factor 
(NGF) in the early stages of neuronal differentiation, using a well-established model 
of rat pheochromocytoma (PC 12) cells. A microarray study performed by our 
co-investigators at the Hong Kong University of Science and Technology showed 
that in the early stage of differentiation, NGF treatment (12 hours) increased 
cyclooxygenase-1 (COX-1) mRNA expression. Since COX-1 is required for the 
production of precursors for the synthesis of prostanoids fiom arachidonic acid, the 
objective of the present study was to determine if NGF had any effect on prostanoid 
receptors signaling in PC 12 cells. 
First, we characterized the prostanoid receptor expression pattern in PC 12 cells 
grown in complete culture medium with high serum supplement (as used for general 
maintenance of undifferentiated cells) or cells treated with NGF (50 ng/ml) for 32 
hours in low-serum medium (as used for studying the neurotrophic action of NGF) 
after pre-labeling cells with [^H]inositol or [^HJadenine. None of the prostanoid 
receptor agonists tested produced significant changes in [^H]inositol phosphates 
([^H]]P) or [3H]CAMP production, which suggested that no Gq- or Gs-coupled 
prostanoid receptors were expressed by PC 12 cells. In PC 12 cells grown in complete 
culture medium, the EP3 receptor agonists (PGE2, sulprostone and ONO-AE-248) 
inhibited forskolin-stimulated [^H]cAMP production, which suggested the presence 
of a Gi-coupled EP3 receptor. Furthermore, this EP3 agonist-mediated response was 
attenuated in NGF-treated cells, suggesting that EP3 receptors were expressed in 
PC 12 cells, and that NGF might reduce EP3 receptor signaling. 
As we had only studied the effect of NGF in PC 12 cells at 32 hours, we made a 
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more extensive study of the time course effect of NGF on EP3 receptor signaling in 
PC 12 cells and compared the responses of NGF-treated cells with control cells in 
low-serum medium. Since we had demonstrated that EP3 was the only EP receptor 
subtype found in PC 12 cells, we chose PGE2 for further study and tested the effect of 
NGF on PGE2-mediated inhibition of forskolin-stimulated [^H]cAMP over 6 days. 
Our results suggested that the decrease of EPS receptor-mediated responses seen at 
32 hours was NGF-independent, and was due to transfer of PC 12 cells from a 
serum-rich culture medium to the low-serum medium. 
Although NGF did not affect EP3 receptor signaling in PC 12 cells, we nonced 
that NGF could dramatically increase forskolin-stimulated AC activity after 4 to 6 
days treatment. As the increased activity of AC might play an important role in the 
differentiation process, we therefore proceeded to study the effect of NGF on AC in 
PC 12 cells. When NGF was removed after 2 days, there was no subsequent enhanced 
response of PC12 cells to forskolin. In contrast, the enhanced response to NGF was 
maintained on day 6 when NGF was removed after 4 days treatment. NGF was found 
to induce neurite extensions after 2 days treatment, and increased the proportion of 
PC 12 cells having neurite extensions in a time-dependent manner over 6 days 
treatment. However, neurites were not maintained when NGF was removed after 2 or 
4 days. Therefore, we concluded that cAMP production was involved in the 
NGF-induced initiation of neurite outgrowth in PC 12 cells, and continual presence of 
NGF was required to maintain neurites, probably in a cAMP-independent way. 
We proposed that the enhanced activation of AC by forskolin in NGF-treated 
PC 12 cells might be due to a synergistic interaction between forskolin and an 
endogenous activator of a Gs-coupled GPCR. We have demonstrated the presence of 
Gs-coupled A2A receptors in PC 12 cells, and their activation might be involved in the 
enhanced response to forskolin due to the release of adenosine during NGF-mediated 
ii 
neuronal differentiation. However, the preliminary tests suggested that adenosine 
deaminase (to destroy endogenously produced adenosine) or A2A receptor antagonist 
(to block the effect of endogenously produced adenosine) appeared not to affect the 
enhanced effect of NGF on AC. 
Taken together, our results demonstrated that the EP3 receptors were the only 
prostanoid receptors expressed in PC 12 cells but their expression was not regulated 
by NGF. Furthermore, NGF was found to enhance forskolin-stimulated AC activity 
in PC 12 cells, and this effect was persistent after 4 days NGF treatment but was not 
maintained when NGF was removed after 2 days. NGF stimulated neurite production 
of PC 12 cells ill a time-dependent manner, and NGF was indispensable for the 
maintenance of neurites. These valuable findings may allow the better understanding 
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1.1 Objectives and overview of this study 
The aim of this study was to examine the signal transduction pathways which 
were regulated by nerve growth factor (NGF) during the early stages of neuronal 
differentiation, and this work was in collaboration with The Hong Kong University 
of Science and Technology (HKUST). We choose rat pheochromocytoma (PC 12) 
cells, which is a well-established model for studying neuronal differentiation and as 
they can respond to NGF and differentiate into a neuronal phenotype. When 
compared with stem cells, which is the ideal model for neuronal differentiation, the 
use of PC 12 cells still has its own advantages, such as it is easier for their 
maintenance and numerous published literatures can be obtained for references. 
Perhaps, a better understanding of neuronal differentiation will inspire the discovery 
of novel therapeutic targets for neurodegenerative disease. 
The differentiation of neuronal cells is controlled by complex networks of signal 
transduction pathways and gene expression, if they are not regulated appropriately, 
cells will be fail to become functional. Therefore, microarray technology has been 
used to study gene expressions which are regulated by NGF in PC 12 cells. Up to now, 
most of the microarray data focus at a later stage of differentiation in PC 12 cells 
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(after 4 to 5 days NGF treatment) (Lee et a l , 2005). In contrast, we target on the very 
early stage (after 12 h NGF treatment), because the gene regulation at the early stage 
will determine the end stage of differentiation. We would like to perform a novel 
study on how the product of those genes affects NGF-induced neuronal 
differentiation. Our data showed that 324 genes are differentially regulated by NGF 
by at least 1.5 fold in PC 12 cells after 12 h treatment. Of interest to us was that the 
cyclooxygenase-1 (COX-1) mRNA expression level was increased 4-foid by NGF. 
This finding is consistent to Kaplan et a l , which showed that NGF increased COX-1 
mRNA and protein expression in PC 12 cells (Kaplan et a l , 1997). Since COX-1 is 
involved in the synthesis of prostanoids, therefore we speculate if prostanoids and 
their receptors play an essential role in neuronal differentiation. 
In this study, the prostanoid receptor expression in PC 12 cells was determined 
by assaying the second messengers ([^H]IP and [^H]cAMP) produced after the 
activation of any G-protein coupled prostanoid receptor using selective receptor 
agonists. We demonstrated that Gj-coupled EP3 receptors were expressed in PC 12 
cells. After that, we investigated the time course effect of NGF on PC 12 cells, and 
discovered that NGF could enhance forskolin-stimulated [^H]cAMP production of 
PC 12 cells. We attempted to relate this observation to the change of adenylyl cyclase 
(AC) expression by NGF as determined by RT-PCR. In addition, the degree of 
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differentiation of PC12 cells was monitored by measuring the neurofilament heavy 
subunit (NfH) protein expression and by assessing neurite outgrowth. Finally, we 
investigated if the involvement of A2A receptor activity was the possible explanation 
for the enhancement of forskolin-stimulated [^H]cAMP production in NGF-treated 
PC12 cells. 
1.2 Rat pheochromocytoma (PCI2) cells 
PC 12 cells were established from a transplantable rat adrenal 
pheochromocytoma in 1976 (Greene & Tischler，1976). PC 12 cells respond to nerve 
growth factor (NGF) and undergo a dramatic morphological change and acquire 
characteristics of sympathetic neurons. In normal growth medium, the PC 12 cells 
have a round shape and do not extend neurite-like processes (Fig. 1.1 A). However, 
when the PC 12 cells are exposed to NGF, proliferation ceases and they differentiate 
into neuronal cell phenotype with long neurites (Fig. 1.IB). 
Because PC 12 cells possess the above properties, they have become a 
commonly used cell model to study how neuroblasts differentiate into mature 
neurons under the influence of NGF (Kaplan et al., 1994; Birkaya & Aletta, 2005; 
Arthur et a l , 2007). Also, NGF is found to act as a survival factor for PC 12 cells 
under serum-free conditions (Greene, 1978)，thus PCI2 cells are also employed for 
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the study of the mechanisms of neuronal cell apoptosis (Shimoke et al., 2005; 
Kavanagh et al., 2006; Jiang et al., 2007). 
1.3 Prostanoids and their receptors 
Prostanoids are group of molecules comprising prostaglandins (PGs) and 
thromboxanes (TXs), which exert a variety of actions in various tissues and cells. For 
examples, prostanoids are involved in the regulation of the smooth muscle 
contraction and relaxation (Tilley et al., 2003; Allen et al.，2006), the glomerular and 
distal tubular functions in the kidney (Dominguez et al., 1984)，and the secretion and 
motility of the gastrointestinal tract (Dey et al., 2006). 
Prostanoids are synthesized by COX pathway under both physiological and 
pathological stimuli. COX exists as two isoforms referred to as COX-1 and COX-2 
(Smith et al., 2000), and are about 60% identical with the catalytic regions being 
conserved (Langenbach et al., 1995). COX-1 is a constitutively expressed enzyme in 
many tissues, which provides various "housekeeping" functions like to strengthen 
gastric mucosa against injury, to regulate platelet aggregation and renal blood flow 
(Chan et al., 2005; Kawada et a l , 2005; Peskar, 2001). In contrast, COX-2 is 
normally not detectable and must be induced by the pro-inflammatory agents like 
cytokines and lipopolysaccharide (Franciosi et al., 2005; Huang et al., 1998; Yang et 
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al.’ 2007). However, COX-2 is expressed constitutively in the central nervous system 
and is involved in nociceptive processes (Martin et al., 2007). COX-2 is also 
constitutively expressed in other tissues like in colon and kidney (Adegboyega & 
Ololade, 2004; Bemardini et al., 2006). In PC12 cells, COX-1 is constitutively 
expressed and being elevated by NGF (Kaplan et al., 1997). In contrast, COX-2 is 
normally not found in PC 12 cells (Arenander et al., 1989), 
The synthetic process of prostanoids is piesented in Fig. 1.2. The starting 
material for the synthesis of prostanoids is arachidonic acid, which is derived from 
the membrane phospholipids by the action of phospholipase A2 (PLA：). The 
arachidonic acid is converted to prostaglandin G2 (PGG2), and then to prostaglandin 
H2 (PGH2) by the subsequent actions of COX. PGH2 then acts as the common 
intermediate for the synthesis of the five prostanoids: prostaglandin D2 (PGD2), 
prostaglandin E2 (PGE2), prostaglandin Fia (PGF2a), prostacyclin (PGI2) and 
thromboxane A2 (TXA2), by their corresponding synthase (Smith, 1992). Prostanoids 
formed are then released outside of the cells facilitated by a prostaglandin transporter 
(Lu & Schuster，1998). Because prostanoids like PGI2 and TXA2 have a very short 
half-life, they have to work locally at the site of their production. 
Prostanoids mediate their actions through the activation of their 
corresponding prostanoid receptors. There are five classes of prostanoid receptors, 
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designated as DP for PGD2 receptors and EP, FP, IP, and TP for PGE2, PGFja, PGI2 
and TXA2, respectively (Nammiya et al., 1999; Breyer et al.，2001). Two receptor 
subtypes are found for DP (DPI and DP2) and four subtypes for EP (EPl-4) (Breyer 
et al., 2001;Hirai et al.，2001). 
The prostanoid receptor family belongs to the G-protein coupled receptors 
superfamily (GPCRs) (Nammiya et al., 1999). All GPCRs share a common structure 
and are integral membrane proteins with seven transmembrane helices (Muller, 
2000). Each prostanoid receptor coupled with a G-protein for their signal 
transduction upon ligand binding. The IP, DPI, EP2 and EP4 receptors coupled 
principally to Gs, and their activation lead to increase of intracellular cyclic 
adenosine monophosphate (cAMP) through the stimulation of adenylyl cyclase (AC) 
(Nammiya et al., 1999). On the contrary, activation of EP3 or DP2 receptors lead to 
decrease of cAMP formation as it is coupled to Gj and inhibits AC activity (Hirai et 
al” 2001; Nammiya et al., 1999). The EPl , FP and TP receptors coupled to Gq which 
can activate phospholipase C (PLC) and this leads to the production of two second 
messengers, inositol 1,4,5-trisphosphate (IP3) which mobilizes intracellular calcium, 
and 1,2-diacylglycerol (DAG) which activates protein kinase C (PKC) (Nammiya et 
al., 1999). 
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1.4 Roles of prostanoids 
Prostanoids mediate various actions under different physiological conditions. 
Prostanoids play an important role in the central nervous system. PGD2 is proposed 
to be a mediator to induce sleep in rats and other mammals (Hayaishi, 1991). 
Infusion of prostaglandin PGD2 into the lateral ventricle of the brain induced an 
increase in the amount of non-rapid eye movement sleep, accompanied with an 
increase of the extracellular adenosine level in wild-type mice (Mizoguchi ei al., 
2001). The accumulation of adenosine in the extracellular space was found to 
increase the sleep propensity (Porkka-Heiskanen, 1999). However, in mice deficient 
in the DP receptor, the infusion of PGD2 did not promote the accumulation of 
adenosine (Mizoguchi et al., 2001). Therefore, PGD2 plays a significant role in sleep 
induction. 
Also, prostanoids are important mediators of inflammation. Major 
characteristics of acute inflammation like swelling which is caused by vasodilation, 
and pain, are mediated by prostanoids. During inflammation, PGE2 and PGI2 were 
found to be highly expressed at the inflammatory sites (Davies et al, 1984). Together 
with other inflammatory mediators like histamine and bradykinin, PGE2 and PGI2 
induce an increase in vascular permeability and hyperalgesia (Bley et al., 1998; 
Davies et al, 1984). Moreover, PGI2 was found to mediate the hyperaglesic response 
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through the activation of IP receptors (Murata et al.’ 1997). Both the wild-type mice 
treated with indomethacin, an inhibitor of COXs (Smith et al., 1994)，and the mice 
deficient in IP receptor, appeared to be less sensitive to the acetic acid-induced 
writhing test (Murata et a l , 1997). 
The most prominent effects of PGF2a are on reproduction and parturition. It was 
reported that PGFza metabolite showed a linear correlation with time and number of 
ovulations in rabbit ovary (Schlaff et al., 1983). PGF2a also regulates luteal cell 
progesterone production and synchronizes ovulation (Klian-Dawood et al., 1989; 
Momcilovic et al., 1998). PGF2ais important for animals to perform parturition. The 
mice deficient in FP receptor have normal ovulation, fertilization and implantation as 
the wild-type mice, but cannot perform parturition due to the lack of labor (Sugimoto 
et al., 1997). Moreover, the administration of COX inhibitor which inhibited the 
PGF2a synthesis led to an increase in the average length of gestation and delayed 
parturition (Chan et al., 1991; Lewis & Schulman, 1973). 
The main function of TXA2 is in hemostasis. The mice deficient in TP receptor 
have prolonged bleeding times, and their platelets appear not to aggregate after 
exposure to TP receptor agonists (Thomas et al., 1998). In humans, it was 
demonstrated that patients having a mutated TP receptor was the cause of impaired 
platelet aggregation (Hirata et al., 1994). 
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Among all the prostanoids, PGE2 plays the most diverse actions in different 
parts of body, as PGE2 can mediate its action through four EP receptor subtypes. 
Activation of EPl receptors was reported to inhibit osmotic water permeability 
induced by arginine-vasotocin in the frog urinary bladder (Bachteeva et al., 2007), 
and is required for the increase of carbonate secretion in response to mucosal 
acidification in the rat stomach (Takeuchi et al., 2006). The EP2 receptors can induce 
cAMP production and Ca^ "^  release from intracellular stores of astrocytes (Di Cesare 
et al., 2006). In spinal cord, the EP3 receptors participate in the synthesis of nitric 
oxide (NO) which is essential for pain transmission (Matsumura et al., 2005). 
Stimulation of EP4 receptorb can accelerate the regeneration of bone under bone 
injury in rat (Tanaka et a l , 2004). 
1.5 Nerve growth factor (NGF) and its receptors 
The actions of NGF are via the activation of two receptors, the 
tropomyosin-related kinase (Trk) family of receptor tyrosine kinases, and the p75 
receptor which belongs to the superfamily of the tumor necrosis factor (TNF) 
receptor (Ye, 2005). The Trk receptor family has three subtypes, Trk A, TrkB and 
TrkC, and NGF mediates different cellular effects through the activation of TrkA 
receptor (Rankin et al,, 2005). One of the functions of p75 receptor is to provide 
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discrimination of the binding of different neurotrophins to Trk receptors. For 
example, brain-derived growth factor (BDNF), neurotrophin-3 and neurotrophin-4/5, 
can all bind to TrkB receptors, but only BDNF can elicit functional response in the 
presence of p75 receptors (Bibel et a l , 1999). Similarly, NT-3 normally did not 
induce neurite outgrowth of PC 12 cells, but induced neurite outgrowth through TrkA 
receptors in a mutant PC 12 cell line with decreased expression of p75 receptors 
(Benedetti et al., 1993). The p75 receptors have pro-apoptotic effects but also 
mediate NGF-induced survival signaling in PC 12 cells (Bui et a l , 2001; Yan et al., 
2005). 
When NGF binds to TrkA receptors, it triggers receptor dimerization and kinase 
activation by phosphorylation of the tyrosines in the cytoplasmic domain of TrkA 
receptors (Patapoutian & Reichardt，2001). After this phosphorylation, adapter 
proteins are recruited for the regulation of different intracellular signaling pathways, 
including the Ras/extracellular-signal-regulated kinase (ERK) protein kinase, the 
phosphatidylinositol-3-OH kinase (PI3K)/Akt kinase pathway and phospholipase 
C-yl (PLC-7I) (Kaplan & Miller, 2000). 
1.6 Change of gene expressions by NGF in PCI2 cells 
The major effects of NGF on PC 12 cells are the induction of growth arrest, 
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accompanied by the elongation of neurites and electrical excitability (Greene & 
Tischler, 1976). In order to achieve these effects, NGF must alter the gene expression 
of PC 12 cells. Different approaches have been employed to identify genes which are 
changed in PC 12 cells by NGF treatment, including the use of cDNA microarray 
analysis (Lee et al., 2005), comparative expressed-sequence-tag analysis (Lee et al.， 
1995) and serial analysis of gene expression (Angelastro et al., 2000). The results 
showed that at least 1000 genes in PC 12 cells were regulated by NGF. 
NGF triggers cell cycle arrest in PC12 cells. Epidermal growth factor (EGF) 
was found to promote proliferation instead of differentiation of PC 12 cells (Vaudry et 
al., 2002). Therefore, it is logical to see that the EGF receptors were down-regulated 
upon NGF treatment, which facilitates cell cycle exit and differentiation of PC 12 
cells (Lazarovici et a l , 1997; Liu et al., 2000). NGF also down-regulated gene 
transcripts which are involved in DNA replication (Angelastro et al., 2000). 
NGF also regulates genes which favor differentiation of PC 12 cells. For 
example, neuritin, which was involved in axon growth (Cantallops et al., 2000), was 
up-regulated by NGF (Lee et al., 2005; Cappelletti et al., 2007). G�pro te ins which 
are concentrated at the growth cones in NGF-treated PC 12 cells (Zubiaur & Neer， 
1993), were up-regulated in both mRNA and protein levels (Andreopoulos et al., 
1995; Angelastro et al., 2000). During differentiation, neurite extensions were 
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observed which definitely required new synthesis of phospholipids. 
Phosphatidylcholine is one of the phospholipids for the formation of cell membrane, 
and its synthesis requires CTP:phosphocholine cytidylytransferase (CT) (Taneva et 
al., 2005). NGF can elevate the expression of CTp2 isoform in PC 12 cells during 
neurite outgrowth (Carter et a l , 2003). Phospholipase D (PLD), which hydrolyses 
phosphatidylcholine and other phospholipids to generate phosphatidic acid, was also 
increased by NGF in PC 12 cells, which might facilitate membrane transport to 
replenish plasma membranes (Hayakawa et a l , 1999; Min et al., 2001). 
In summary, differentiation of PC 12 cells triggered by NGF is a complex 
process, and is controlled by regulation of multiple genes. Although with the support 
of modem techniques for the quick analysis of changes of gene expression induced 
by NGF, relatively few have been evaluated with respect to their functional 
significance. Therefore, there is still a long way to go to fully understand the 
NGF-induced differentiation of PC 12 cells. 
1.7 Signaling pathways involved in NGF-induced differentiation of PCI2 cells 
The ERK is activated by growth factors and is involved in cell proliferation or 
differentiation (Marshall, 1995). The cellular action of ERK depends on the duration 
of its activation. It has been reported that NGF could induce a sustained activation of 
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ERK which triggered differentiation, while the EGF only induced a transient 
activation of ERK kinase to stimulate proliferation in PC12 cells (Dikic et a l , 1994; 
Traverse et al., 1994). On the other hand, in PC 12 mutant cells where NGF can only 
induce transient ERK activation, there was no morphological change upon NGF 
treatment (Yaka et al., 1998). These findings suggested that a sustained activation of 
ERK was required for the differentiation process in the PC 12 cells. Besides the 
Ras/ERK pathway, the PI3K/Akt pathway is also involved in differentiation of PC 12 
cells. NGF activates the PI3K/Akt pathway, which is particularly important for 
promoting survival under a wide variety of circumstances (Briinet et al, 2001; Wu & 
Wong, 2005). However, the PI3K/Akt pathway also participates in the initiation and 
maintenance of neurite outgrowth triggered by NGF in PC 12 cells (Jackson et al., 
1996; Kobayashi et al., 1997; Kita et al., 1998). In order to become fully functional, 
PC 12 cells treated with NGF must have ability to synthesize and store 
neurotransmitter. NGF induced the expression of tyrosine hydroxylase, which is the 
rate-limiting enzyme for the synthesis of catecholamines, and is dependent on 
Ras/ERK pathway (Suzuki et al., 2004). In contrast, the induction of gene expression 
responsible for the synthesis of acetylcholine was mainly regulated by the P13K/Akt 
pathway (Madziar et al., 2005). As a result, the differentiation of PC 12 cells is 
controlled by multiple pathways, and their combinatory effect may determine the 
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ultimate fate of these cells. 
1.8 Classification of adenylyl cyclases 
AC is the enzyme which catalyzes the conversion of ATP to cAMP, and cAMP 
is an important second messenger in eukaryotic signal transduction. In mammalian 
cells, there are two major types of AC, the transmembrane AC (tmAC) and the 
soluble AC (sAC). 
There are nine tmAC isoforms (ACl to AC9) and their catalytic activities are 
regulated by GPCRs (Hanoune & Defer, 2001). All of the tmAC isoforms except 
AC9 can be activated by forskolin (Simcnds, 1999). These nine isoforms can be 
classified into four groups: Group I AC isoforms include ACl , AC3 and ACS, which 
are stimulated by Ca^^ and calmodulin, Group II AC isoforms include AC2, AC4 and 
AC7, which are stimulated by Gp丫 and PKC phosphorylation, Group III AC isoforms 
include ACS and AC6, which are inhibited by PKA, and Group IV isoform only 
contain AC9, which is inhibited by Ca^ "^  and calcineurin (Paterson et al., 2000; 
Chang et al., 2003a). Unlike the tmAC, sAC is not regulated by GPCRs and is 
insensitive to forskolin (Buck et al., 1999; Litvin et al, 2003). The activity of sAC is 
regulated by bicarbonate (Chen et al., 2000) and calcium (Litvin et al., 2003). 
The increase of intracellular cAMP level is involved for the stimulation of 
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differentiation of PC 12 cells, because cAMP activates ERK in PC 12 cells (Frodin et 
al., 1994; Young et a l , 1994; Erhardt et a l , 1995; Vossler et al., 1997). In addition, 
the analog of cAMP, dibutyryl cAMP, can initiate neurite outgrowth by itself in PC 12 
cells (Gunning et al., 1981b; Heidemann et al., 1985; Hayakawa et al., 1999). 
Therefore, AC under regulation by various stimuli is related to the differentiation of 
PC12 cells. 
1.9 Methods to study differentiation of PC12 cells 
NGF triggers neurite outgrowth of PCI 2 cells, therefore it is a direct method to 
quantify the degree of differentiation by neurite assay, which is a typical assessment 
performed by counting the proportion of cells expressing neurites of length more 
than certain cell diameter or by direct measurement of neurite length (Perry et al., 
2002; Attiah et al., 2003; Cappelletti et al., 2007). However, this method is not easy 
to perform when we have to analyze large amount of samples as it is labor-intensive, 
and the assessment of neurites is dependent on the observer, so it is not a fully 
objective measurements. As a result, it is desirable to develop alternative assessment 
on differentiation of PC 12 cells, such as the measurement of neuronal markers or 
metabolic enzymes which are obviously regulated by NGF during differentiation. 
Several protein expressions were regarded as the markers of differentiation, such as 
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neurofilament proteins and axonal growth associated protein 43 (GAP-43), and their 
expression level is used as a reflection of the degree of differentiation (Lindenbaum 
et al., 1987; Edsall et al., 1997; Das et a l , 2004; Liu et a l , 2006). In addition, 
measurement of enzyme activity which is changed by NGF has also been employed. 
NGF was reported to suppress the synthesis of lactate dehydrogenase (LDH), while 
increased the activity of NADH-dehydrogenase in PC 12 cells (Calissano et al., 1985; 
Cattaneo et al., 1985; Rhodes et al., 1989). The activity of LDH and 
NADH-dehydrogenase was increased and decreased, respectively, by NGF in a 
dose-dependent manner in PC 12 cells (Ohuchi et al., 2002). 
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_ 
Fig. 1.1. Cell morphology of PC12 cells. (A) PC12 cells maintained in complete 
culture medium. (B) PC 12 cells treated with 50 ng/ml of NGF in low-serum medium 
for 6 days. 
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Materials and methods 
2.1 Materials 
8-[^Hl-adenine (specific activity 29.0 Ci/mmol) was purchased from Amersham and 
stored at 4 °C. 
1,4-dithiothreitoI (USB) 
Acetic acid (Ridedel-de Haen) 
Acrylamide (30%, Sigma) 
Adenosine 5'-triphosphate (ATP, Sigma) was dissolved in distilled water and 
freshly prepared before assay. 
Adenosine deaminase from bovine spleen (Sigma) 
Ammonia solution (25%, BDH) 
Ammonium formate (Standard) 
Ammonium persulfate (APS, Bio-Rad) was prepared as 10% (w/v) solution by 
dissolving 0.5 g powder in 5 ml distilled water, aliquoted and stored at - 2 0 � C . 
Anti-neurofilament heavy subunit antibody (Covance) 
Alumina (neutral type WN-3, Sigma) 
Bovine serum albumin (BSA，Sigma) 
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Bradykinin (Sigma) was prepared as a 10 mM stock in 5% acetic acid and stored at 
-20 t：. 
Bromophenol blue (Sigma) 
n-Butanol (Sigma) 
CGS21680 (Sigma) was prepared as a 10 mM stock in DMSO and stored at -20 °C. 
Cicaprost was a gift from Schering which was prepared as a 1 mM stock in DMSO 
and stored at - 2 0 � C . 
Chloroform (Sigma) 
Complete protease inhibitor (Roche) was prepared as 25X stock by dissolving I 
tablet in 2 ml distilled water, being aliquoted and stored at - 2 0 � C . 
Dimethyl sulphoxide (DMSO, Sigma) 
DNase I (Invitrogen) 
dNTP Mix (Invitrogen) 
Dowex AG1-X8 (100-200 mesh, formate form) was purchased from Bio-Rad. 
Dowex AF50W-X4 (200-400 mesh, hydrogen form) was purchased from Bio-Rad. 
Dulbecco's modified Eagle's medium (DMEM, Gibco) was dissolved in distilled 
water with the addition of 3.7 g NaHCOs per litre of medium. The medium was 
adjusted to pH 7.2, then filter sterilized and stored at 4 °C. 
ECI/M anti-mouse IgG, horseradish peroxidase-linked (Amersham) 
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ECL chemiluminescence kit (Amersham) 
EDTA (Ethylenediamine-tetraacetic acid, Sigma) 
Ethanol (absolute, Merck) 
Ethidium bromide (Sigma) 
Expand High Fidelit/Lus p c R System (Roche) 
Fetal bovine serum (FBS, Gibco) 
Formic acid (BDH) 




Heat-inactivated horse serum (HIHS, Gibco) 
HEPES (N-(2-Hydroxyethyl)piperazine-N'-2-ethanesulfonic acid, Sigma) 
Hydrochloric acid (HCl, BDH) 
Hybond nitrocellulose membranes (Amersham) 
IBMX (3-isobuty-1 -methyl-xanthine, Sigma) was prepared as 100 mM stock in 
DMSO and stored at - 2 0 � C . 
Imidazole (Sigma) 
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Inositol, myo-|2-^H(N)] (specific activity 18.5 Ci/mmol) was purchased from NEN 
Life Science Products, Inc. and stored at 4 � C . 
Isopropanol (BDH) 
Lithium chloride (Sigma) was prepared as 1 M solution in distilled water and stored 
a t4°C . 
Micro BCA Protein Assay Kit (Pierce) 
iVI-MLV reverse transcriptase (Invitrogen) 
NGF (mouse nerve growth factor 2.5s, grade II) was purchased from Alomone Labs 
(Israel). 25 )j.g lyophilized powder was dissolved in 0.5 ml sterile DMEM to a 
concentration of 50 jig/mi, aliquoted and stored at - 7 0 . 
Noii-tat milk powder (Nestle) 
Oligo d(T)20 primer (Invitrogen) 
ONO-AE-248 was a gift from ONO Pharmaceuticals Co. which was prepared as 10 
niM solution in DMSO and stored at - 2 0 � C . 
ONO-AEl-259 was a gift from ONO Pharmaceuticals Co. which was prepared as 10 
mM solution in DMSO, aliquoted and stored at -20 °C. 
ONO-AEl-329 was a gift from ONO Pharmaceuticals Co. which was prepared as 10 
mM solution in DMSO, aliquoted and stored at - 2 0 � C . 
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ONO-AE3-240 was a gift from ONO Pharmaceuticals Co. which was prepared as 10 
mM solution in DMSO, aliquoted and stored at - 7 0 � C . 
ONO-DI-004 was a gift from ONO Pharmaceuticals Co. which was prepared as 10 
mM solution in DMSO and stored at - 2 0 � C . 
OptiPliase ‘Hi-safe’ 3 (Pharmacia Biotech) 
Penicillin/Streptomycin solution (Gibco) 
Potassium chloride (KCl, Sigma) 
Potassium phosphate monobasic (KH2PO4，Sigma) 
Primer pairs (In vitro gen) 
Prostaglandin D2 (PGD2, Cayman) was dissolved MI ethanol at 10 mM and stored at 
-20 . 
Prostaglandin E2 (PGE2, Sigma) was dissolved in ethanol at 10 mM and stored at 
-20 °C. 
Prostaglandin Fia (PG Fja, Sigma) was dissolved in DMSO at 10 mM and stored at 
-20 t . 
Polyprep column (Bio-Rad) 
Rat tail Collagen, T^pe I (BD Bioscience) was prepared in 0.02 N acetic acid at 
4.05 mg/ml and stored at 4 °C. 
RNaseOUTpTM ribonuclease inhibitor (Invitrogen) 
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Sodium bicarbonate (NaHCOs, Sigma) 
Sodium chloride (NaCl, Sigma) 
Sodium dodecyl sulfate (SDS, Bio-Rad) 
Sodium hydroxide (NaOH, Sigma) 
Sodium phosphate dibasic (NazHPOg’ Sigma) 
Sodium pyrophosphate (NadPzO?, Sigma) 
Sulprostone (Caymen) was dissolved in DMSO at 10 inM and stored at - 2 0 � C . 
TEMED (Sigma) 
Trichloroacetic acid (TCA, Sigma) 
Triton X-100 (Sigma) 
Trizina base (Sigma) 
T R I Z O L reagent (Invitrogen) 
Trypan blue (Blue) 
Trypsin/EDTA (Sigma) 
U46619 (Sigma) was dissolved in ethanol at 2.85 mM and stored at - 2 0 � C . 
ZM241385 (Tocris) was dissolved in DMSO at 5 mM and stored at -20 °C. 
Common laboratory reagents not listed (ACS grade) were purchased from Sigma. All 
disposable culture plates were supplied by Nunc. 
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2.2 Cell culture medium and buffers 
Complete culture medium was prepared by mixing 25 ml FBS (5% v/v), 50 ml 
HIHS (10% v/v) and 425 ml DMEM in 500 ml bottle and stored at 4 � C • Penicillin 
(100 units/ml) and streptomycin (100 |ig/ml) were added before use. 
Low-serum medium was prepared by mixing HIHS (1 % v/v) with DMEM. 
Penicillin (100 units/ml) and streptomycin (100 )Lig/ml) was added before use. 
Phosphate-buffered saline (PBS) was prepared with the following ACS reagents 
supplied by Sigma: KCl (2.7 mM), KH2PO4 (1.4 mM), NaCl (137 mM) and 
Na2HP04 (8.1 mM) dissolved in distilled water. The PBS was adjusted to pH 7.5, 
filter sterilized and stored at 4 °C. 
2.3 Buffers and solutions for assay of [^HJinositol phosphates ([^H|IP) 
production 
HEPES-buffered saline (HBS) was prepared with the following ACS reagents 
supplied by Sigma: HEPES (15 mM), NaCl (140 mM), KCl (4.7 mM), CaCb (2.2 
mM), MgCb (1.2 mM) and KH2PO4 (1.2 mM) dissolved in distilled water. The HBS 
was adjusted to pH 7.4, filter sterilized and stored at 4 °C. Glucose (11 mM) was 
added immediately before use. 
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Formic acid (1 M) was prepared by diluting 37.73 ml 26.5 M stock in 1 L distilled 
water and stored at room temperature. 
Formic acid (20 mM) was prepared by mixing 20 ml 1 M formic acid with distilled 
water and made up to 1 L and stored at room temperature. 
Ammonia solution (0.05%) was prepared by dissolving 2 ml 25% ammonia 
solution in distilled water and made up to 1 L. It was stored at room temperature. 
Amnionium for mate (4 M) was prepared by dissolving 252.54 g ammonium 
formate powder in distilled water and made up to 1 L. It was stored at room 
temperature. 
Ammonium formate (2 M)/formic acid (0.1 M) was prepared by dissolving 252.24 
g ammonium formate powder with 200 ml 1 M formic acid and distilled water and 
made up to 2 L. It was stored at room temperature. 
Ammonium formate (40 mM) /formic acid (0.1 M) was prepared by dissolving 
5.04 g ammonium formate with 200 ml 1 M formic acid and distilled water and made 
up to 2 L. It was stored at room temperature. 
Lithium chloride (1 M) was prepared by dissolving 424 mg lithium chloride powder 
in 10 ml distilled water and stored at 4 � C . It was diluted in HBS to a final 
concentration of 20 mM. 
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2.4 Buffers and solutions for assay of [^H]cAMP production 
HEPES-buffered saline (HBS) was the same as used in [^H]-IP production assay. 
Imidazole solution (0.5 M) was prepared by dissolving 104.5 g imidazole powder 
and 27 g NaOH in distilled water and made up to 2 L. The solution was adjusted to 
pH 7.5 and stored at room temperature. 
Imidazole solution (0.1 M) was prepared by mixing 200 ml 0.5 M imidazole 
solution with distilled water and made up to 1 L when required. 
Hydrochloric acid (4 M) was prepared by diluting 330 ml 12.2 M stock with 670 ml 
distilled water and stored at room temperature. 
Hydrochloric acid (1 M) was prepared by mixing 250 ml 4 M HCl with 750 ml 
distilled water and stored at room temperature. 
Trichloroacetic acid (5%) was prepared by dissolving 25 g TCA in 500 ml distilled 
water and stored at 4 °C. 
IBMX was prepared as 100 mM stock in DMSO and stored at - 2 0 � C . It was diluted 
in HBS to a final concentration of 1 mM. 
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2.5 Buffers and solutions for Western blotting 
Lysis buffer was prepared with the following reagents supplied by Sigma: Trizma 
base (50 mM), NaCl (100 mM), EDTA (5 mM), Na4P207 (67 mM), and Triton X-100 
(0.01%) in distilled water. The solution was adjusted to pH 7.5 and made up to 1 L. It 
was stored at 4 °C. Appropriate amount of 25X complete protease inhibitor was 
added to give a IX working concentration just before use. 
Stacking buffer was prepared by dissolving 30.2 g Trizma base in 400 ml distilled 
water. The solution was adjusted to pH 6.8 with HCl and made up to 500 ml and 
stored at 4 ‘:C. 
Separating buffer was prepared by dissolving 90.8 g Trizma base in 400 ml distilled 
water. The solution was adjusted to pH 8.8 with HCl and stored at 4 . 
SDS solution (10%) was prepared by dissolving 10 g SDS in distilled water. The 
volume was made up to 100 ml and stored at room temperature. 
Running buffer (lOX) and transfer buffer (lOX) was prepared by dissolving 60 g 
Trizma base and 288 g glycine in distilled water. The volume was made up to 2 L and 
stored at room temperature. 
Running buffer (IX) was prepared by mixing 200 ml lOX running buffer and 20 ml 
10% SDS solution in distilled water. The volume was made up to 2 L and stored at 
room temperature. 
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Transfer buffer (IX) was prepared by mixing 600 ml lOX transfer buffer and 900 
ml absolute ethanol in distilled water. The volume was made up to 6 L and stored at 
room temperature. 
Sample buffer (6X) was prepared by mixing 7 ml stacking buffer, 1 g SDS, 0.93 g 
1,4-dithiothreitol, 3 ml glycerol and 1.2 mg bromophenol blue in 10 ml distilled 
water. It was aliquoted and stored at -20 
Ammonium persulfate (APS) solution (10%) was prepared by dissolving 0.5 g 
APS in 5 ml distilled water. It was aliquoted and stored at - 2 0 � C . 
n-Butanol (water-saturated) was prepared by mixing 300 ml n-butanol with 100 ml 
distilled water. The top clear layer was used after it separated into 2 phases. 
Tris buffer saline (TBST) (lOX) was prepared by dissolving 121.11 g Trizma base 
and 175.32 g NaCl in 600 ml of distilled water. The solution was adjusted to pH 7.5, 
and then 10 ml of Tween 20 was added. The volume was made up to 2 L and stored 
at room temperature. 
Tris buffer saline (TBST) (IX) was prepared by diluting 100 ml lOX TBST with 
900 ml distilled water and stored at room temperature. 
Non-fat milk solution (5%) was prepared by dissolving 1 g non-fat milk powder in 
20 ml IX TBST. It was stored a t4 °C . 
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BSA solution (5%) was prepared by dissolving 1 g BSA powder in 20 ml IX TEST. 
It was stored at 4 � C . 
2.6 Methods 
2.6.1 Maintenance of PC12 cells 
PC 12 cells were cultured in 10 ml complete culture medium in a 100 mm 
culture dish in a humidified atmosphere cf 5% C02/95% air at 37 • Cells were 
passaged once a week at approximately 80% confluency, and the medium was 
renewed every two to three days. When subculturing the cells, the medium was 
removed and cells were washed with 3 ml PBS. The PBS was then removed and 2 ml 
culture medium was added. Cells were detached by forceful aspiration and the cell 
suspension was transferred to a 15 ml centrifuge tube. Cells were collected by 
centrifuging at 140 x g for 5 min at room temperature. The supernatant was removed 
and the cell pellet was resuspended in culture medium. The cell number was counted 
using a hemocytometer. When counting cells, 10 cell suspension was mixed with 
10 iiil trypan blue solution, and the cell viability was over 90%. About 3 x 10^ cells 
were then plated in a new culture dish with the addition of 10 ml complete culture 
medium. 
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2.6.2 General culture condition of PC12 cells for NGF treatment 
The culture plates were coated with collagen (0.2 mg/ml, diluted the stock with 
sterile water) for 10 min (use 2 ml or 0.5 ml collagen solution per well for 6-well or 
24-vvell culture plates, respectively). Then, wells were emptied by aspiration and the 
plates were air-dried before use. PC 12 cells were plated in collagen-coated in 2 ml or 
0.5 ml complete culture medium in 6-well or 24-well culture plates, respectively, and 
incubated for 24 h in a humidified atmosphere of 5% C02/95% air at 37 'C. The 
medium was removed and the cells were washed four times with PBS. Then, 
low-serum medium was added for another 24 h in a humidified atmosphere of 5% 
C02/95% air at 37�C • Then, DMEM or NGF (50 ng/ml) was added with day of NGF 
addition defined as Day 0. Culture medium and drugs were replaced every two days, 
as required. For the study of NGF withdrawal effect, the low-serum medium 
containing NGF was removed and replaced with plain low-serum medium. 
2.6.3 Determination of phospholipase C activity in PC12 cells 
2.6.3.1 Principle of assay 
The PLC family consists of 13 isoforms and are activated by either Gq proteins 
or by transmembrane receptors with tyrosine kinase activity. PLC-p possesses a long 
C-tenninal extension which is required for activation by Gq. PLC metabolizes the 
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membrane inositol phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), to 
produce two second messengers, inositol 1,4,5-trisphosphate (IP3) which mobilizes 
intracellular calcium, and 1,2-diacylglycerol (DAG) which activates protein kinase C 
(PKC) (Dean & Beaven，1989). IP3 was rapidly broken down which caused difficulty 
on its estimation. However, lithium ions were found to prevent the breakdown of IP3 
by inhibiting inositol polyphosphate-1 -phosphatase (Inhom and Majerus, 1987) and 
inositol monophosphatase (Fauroux & Freeman, 1999). As a result, the presence of 
lithium ions caused a substantial accumulation of total inositol phosphates, including 
the inositol trisphosphate, bisphosphate and in particular of inositol monophosphate 
(Bcrridge el al., 1982). 
PC 12 cells were pre-labeled with ["H]inositol which was incorporated into 
phosphatidylinositol lipids like PIP2. The total [^Hjinositol phosphates ([^H]IP) 
production after stimulation by agonist were separated using Dowex column 
chromatography. The assay of [^H]IP fraction in the presence of lithium ions 
provides an accurate estimation of the degree of receptor activation of PLC by 
agonist (Chow et al., 2001). 
2.6.3.2 Column preparation 
Dowex AG1-X8 resin was washed twice with distilled water. Resin suspension 
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(2 ml) was then transferred into polyprep columns. The columns were reusable and 
washed with 5 ml 2 M ammonium formate/0.1 M formic acid, 2 ml distilled water 
and then 2 ml 0.05% ammonia solution before use. 
2.6.3.3 Measurement of l^HjlP production 
PC 12 cells (3 X 10^ cells/well) were cultured in 0.5 ml medium in 24-well 
plates as described in section 2.2. Cells were pre-labeled with [^Hjinositol (2 |aCi/ml; 
1 |_iCi八veil) for 32 h before the assay of [^H]IP production. On the day of assay, the 
medium was aspirated and the cells were washed twice with 0.5 ml HBS followed by 
10 min incubation at 3 7 � C in HBS containing LiCl (20 mM) to prevent the 
breakdown of ['H]1P3. The buffer was removed and replaced with 0.5 ml fresh HBS 
(with 20 mM LiCl) followed by the addition of 5 [x\ vehicle or test compounds for 1 
h at 37 °C in a water bath. The reaction was stopped by aspiration of the buffer and 
addition of 0.75 ml ice-cold formic acid (20 mM). The plates were left on ice for at 
least i h for the extraction of acid soluble total [^H]inositol phospholipids fraction. 
[^H]IP was separated from the total [^H]inositol phospholipids by column 
chromatography (Chow et al., 2001), The columns were placed over 20 ml 
scintillation vials and the entire 750 \x\ of formic acid extracts were loaded onto the 
columns, and immediately followed by the addition of 3 ml 0.05% ammonia solution 
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to eliite the total [^H]inositol phospholipids into the scintillation vials. The extracts 
were then mixed thoroughly with 7,5 ml of scintillant (OptiPhase ‘Hi-safe’ 3). 
The columns were then placed over a waste container and washed with 4 ml 40 
mM ammonium formate/0.1 M formic acid. The columns were then placed over 
another set of 20 ml scintillation vials. The [^H]IP fraction was eluted by 5 ml 2 M 
ammonium formate/0.1 M formic acid. The extracts were then mixed thoroughly 
with 10 ml scintillant (OptiPhase ‘Hi-safe’ 3). 
Blank samples (formic acid) were run through the columns in parallel to the test 
samples for the determination of the background count of the columns, and this value 
was subtracted from all the test values. The radioactivities of all the samples were 
measured by liquid scintillation counting (Packard LS2900TR). 
2.6.3.4 Data analysis 
Each experiment was performed in triplicate. The [^H]IP production is 
expressed as [^H]IP/([^H]1P + [^H]inositol phospholipids) x 100. The [^H]IP 
production of the control (cells treated with vehicle only) is defined as 100%, and the 
agonist-stimulated [^H]IP production is normalized against the control and expressed 
as percentage of control. 
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2.6.4 Determination of adenylyl cyclase activity in PC12 cells 
2.6.4.1 Principle of assay 
AC is the enzyme which converts ATP to cAMP, and the increase of cAMP level 
is required for the activation of protein kinase A (PKA). The activity of AC is 
determined by metabolic labeling of the cellular pool of ATP using. [^H]adenine. The 
[^HjcAMP produced in the presence of IBMX (a phosphodiesterase inhibitor to 
prevent the breakdown of [^H]cAMP) after stimulation by agonist was separated 
from other radio-labeled materials using Dowex column chromatography. The 
[^H]cAMP production in the presence of IBMX reflects the activity of AC (Chow et 
al., 2001). 
2.6.4.2 Column preparation 
Dowex AG50W-X4 resin (30 g) was mixed with 60 ml IM HCl. Equal volume 
of resin suspension was transferred into polyprep columns (up tol ml mark of the 
columns). The columns were washed with 4 ml 1 M HCl followed by 10 ml distilled 
water. The columns were reusable and washed with 10 ml distilled water before use. 
Neutral alumina (0.6 g) was put into each polyprep column and the columns 
were washed with 8 ml 0.1 M imidazole solution. The columns were reusable and 
washed with 8 ml 0.1 imidazole solution before use. 
35 
2.6.4.3 Measurement of (^H]cAMP production 
PC 12 cells (3 X 105 cells/well) were cultured in 0.5 ml medium in 24-well 
plates as described in section 2.2. Cells were pre-labeled with [^Hjadenine (2 )iCi/ml; 
1 i^Ci/well) for 24 h before the assay of [^H]cAMP production. On the day of assay, 
the medium was aspirated and the cells were washed twice with 0.5 ml HBS. The 
buffer was removed and replaced with 0.5 ml fresh HBS plus 1 mM IBMX followed 
by the addition of 5 |al vehicle or test compound for 30 min at 37 in a water bath. 
For the study involving the use of inhibitor or antagonist, cells were pre-incubated 
with inhibitor or antagonist for 30 min before the addition of test compound. The 
reaction was stopped by aspiration of the buffer and addition of 1 ml ice-cold 
TCA with 1 mM ATP. The plates were left on ice for at least 1 h for the extraction of 
[^HjcAMP and other radiolabeled materials. 
[^HjcAMP was separated from the total [^H]adenine nucleotides ([^H]AXP) 
by column chromatography (Chow et al., 2001). The Dowex columns were then 
placed over 20 ml scintillation vials and the entire 1 ml acid extracts were loaded on 
to the columns, followed by 3 ml distilled water to elute the [^H]AXP into the 
scintillation vials. The extracts were mixed thoroughly with 7 ml of scintillant 
(OptiPhase ‘Hi-safe，3). 
The Dowex columns were then placed over the alumina columns and washed 
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with 10 ml distilled water. When water had completely mn through both set of 
columns, the alumina columns were placed over another set of 20 ml scintillation 
vials and [^H]cAMP was eluted by 6 ml 0.1 M imidazole solution. The extracts were 
mixed thoroughly with 10 ml of scintillant (OptiPhase ‘Hi-safe’ 3). 
Blank samples (5% TCA) were run through the columns in parallel to the test 
samples for the determination of the background count of the columns, and this value 
was subtracted from all the test values. The radioactivities of all the samples were 
measured by liquid scintillation counting (Packard LS2900TR). 
2.6.4.4 Data analysis 
Each experiment was preformed in duplicate or triplicate. The [^H]cAMP 
production is expressed as % conversion, i.e. [^H]cAMP/([^H]cAMP + [^H]AXP) x 
100. The [^H]cAMP production of the control (cells treated with vehicle only) is 
defined as 100%, and the agonist-stimulated [^H]cAMP production is normalized 
against the control and expressed as percentage of control. 
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2.6.5 Determination of neurofilament protein expression in PCI2 cells by 
Western blotting 
PC 12 cells (3 X 105 cells/well) were cultured in 2 ml medium in 6-well plates as 
described in section 2.2. At the end of drug treatment, medium was aspirated and the 
cells were washed with 1 ml ice-cold PBS. Then, 0.2 ml lysis buffer was added to 
each well and cells were lysed for 60 min on ice. The cell lysates were then 
centrifuged at 15,000 x g for 15 min at 4 The supernatant was collected and 
protein concentrations were determined using a Micro BCA Protein Assay Kit with 
bovine serum albumin (BSA) as standard 
Equal amount of protein (20 ).ig) from the cell lysates were loaded into 6% 
SDS-PAGE gel. After separation of proteins by electrophoresis at I GOV for 90 min, 
proteins were transferred onto Hybond nitrocellulose membranes (Amersham) at 
constant current of 350A for 90 min. Then, the membranes were blocked with 5% 
BSA for 30 min at room temperature and incubated with primary antibody 
(anti-neurofilament antibody, 1:2000) in 3 ml 5% BSA overnight at 4 � C . 
Immunodetection was done with horseradish peroxidase (HRP)-linked anti-mouse 
antibody (1:2000) as the secondary antibody and developed with an ECL 
chemiluminescence kit. The band intensity was quantified by using the computer 
program Scion Image (Scion Corporation, Frederick, USA). 
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2.6.6 Determination of adenylyl cyclase isoform expression in PCI2 cells by 
reverse transcriptase-polymerase chain reaction (RT-PCR) 
2.6.6.1 Isolation of total cellular RNA 
PC 12 cells (3 X 105 cells/well) were cultured in 0.5 ml medium in 24-well plates 
as described in section 2.2. Cells were detached by aspiration with PBS and collected 
by centrifugation. Cells were lysed in 1 ml TRIZOL reagent with repetitive pipetting 
( � 1 5 - 2 0 times). The lysed samples were incubated for 5 min at room temperature to 
permit the complete dissociation of nucleoprotein complexes. Then, 0.2 ml 
chloroform was added to the samples which were shaken vigorously by hand for 15 
sec. The samples were incubated for about 3 min at room temperature and 
ccntrifuged at 12,000 x g for 15 min at 4 °C. Following centrifugation, the upper 
aqueous phase containing RNA was transferred to another microcentrifuge tube, and 
RNA precipitated using 0.5 ml isopropanol and incubated for 10 min at room 
temperature. The samples were centrifuged at 12,000 x g for 10 min at 4 °C, and the 
supematants were removed. The gel-like RNA pellet was washed once with 1 ml 
75% ethanol, and centrifuged at 7,500 x g for 5 min at 4 °C. The supematants were 
then removed and the remaining pellet was partially dried in air for about 5 min. 
Finally, the RNA pellet was dissolved in 10 DEPC-treated water and stored at -70 
� C . RNA extracted from adult rat (male, 150-200 g) cerebral cortex tissue (O.lg) was 
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used as the positive control, and the extraction process was identical to above. 
The concentration and purity of the RNA extract was determined by measuring 
its absorbance at 260 nm (A260) and 280 nm (A280). A pure preparation of RNA 
extract would have an A260/A280 ratio range from 1.5 to 2.0. 
RNA concentration (|Lig/|al) = A260 x 40 x dilution factor / 1000 
An A26oof 1 corresponds to approximately 40 |ig/ml for single-stranded RNA. 
2.6.6.2 Synthesis of first strand cDNA by reverse transcription (RT) 
The extracted RNA was used to synthesize the first strand cDNA using M-MLV 
reverse transcriptase. In order to remo\'e any contamination of genomic DNA, 1 ug 
RNA extract was incubated with DNase I (0.5 units) for 15 min at room temperature. 
Then, the DNase I was inactivated by the addition of EDTA (1.25 mM) and heated 
for 10 min at 6 5 �C in a thermocycler (Stratagene). 
The RNA samples were then incubated with dNTP mix and oligo d(T)20 primer 
for 5 min at 6 5 �C in the thermocycler，and then quickly chilled on ice. After the RT 
buffer (IX), DTT (0.1 |aM) and RNaseOUT™ Recombinant Ribonuclease inhibitor 
(20 U) was added, the samples were incubated for 2 min at 37 °C. MLV reverse 
transcriptase (100 U) was then added and incubated for 50 min at 37 °C. Finally, the 
reaction was inactivated by heating the sample for 15 min at 7 0 � C . The cDNA 
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samples were stored at -20�C before use. 
2.6.6.3 Polymerase Chain Reaction (PCR) 
For each sample, 1 jul cDNA was mixed with forward and reverse primers of the 
targeted sequences (0.4 |iM of each primer) and these sequences were amplified with 
Taq polymerase (0.5 U). The primer sequences used were based on published 
literature (Chang et al., 2003a), and the sequences are listed in Table 2.1. GAPDH 
gene was included as the internal control. For PCR reaction, the reaction mixtures in 
PCR tubes were put into a themiocycler programmed as follows: initial denatiiration 
al 9 5 � C for 5 min, followed by 28 cycles with denatiiration at 95 for 30 sec, 
annealing at 5 8 � C for 30 sec and elongation at 72 "C for 30 sec. In order to complete 
the reaction, the mixture was incubated at 7 2�C for 7 min (Chang et a l , 2003a). The 
PCR products were then stored at 4 � C before agarose gel electrophoresis. 
2.6.6.4 Agarose gel electrophoresis 
The PCR products were resolved by 2.2% agarose gel electrophoresis. Briefly, 
10 PCR products were mixed with 2 6X gel loading buffer. Then, the mixture 
was loaded into the wells of a 2.2% agarose gel containing ethidium bromide, with 
electrophoresis at a constant voltage of 100 V for about 1 h. The PCR products were 
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visualized under UV exposure and the images were captured, and band intensities 
were analyzed with Scion Image. 
2.6.7 Neurite quantification 
PC 12 cells (5 X 104 cells/well) were cultured in 2 ml medium in 6-well plates as 
described in section 2.2. At specific time points, cells were analyzed manually by 
observation using micrcscope under 100 X magnification, or in another way, 5 
images of each well were captured under lOOX magnification using an image 
capturing system (DS Camera Control Unit DS-Ll, Nikon). The images were 
quantified with Scion Image in a way that the observer was unaware of the treatment 
group. One hundred cells per well were scored for neurites equal to or greater than 
that of the cell body diameter. 
2.6.8 Trypan blue exclusion test 
The cell viability of PC 12 cells during the assay of [^H]cAMP production was 
determined by the trypan blue exclusion test. PC 12 cells (3 x 10^ cells/well) were 
cultured in 0.5 ml medium in 24-well plates as described in section 2.2. After the 
drug treatment, assay buffer was removed by aspiration, and cells were incubated 
with 0.2 ml trypsin for 1 min at room temperature. After that, 0.25 ml HBS was 
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added to dilute the trypsin. A total volume of 0.45 ml cell suspension from each well 
was transferred to a microcentrifuge tube containing 0.25 ml serum-containing 
medium (to neutralize the activity of trypsin). Another 0.5 ml HBS was added to 
wash out any remaining cells from the wells. 
Cells were collected by centrifugation at 140 x g for 5 min at room temperature. 
The supernatant was removed and the pellet was resuspended in 0.2 ml HBS. Before 
counting the cells, 10 cell suspension was mixed with 10 |il trypan blue. Viable 
cells will have a clear cytoplasm, while dead cells will have a blue cytoplasm. The 
experiment was performed in triplicate and each sample was counted in duplicate. 
The percentage of viable cells was defined as: counts of cells with clear 
cytoplasm/total cell counts x 100%. 
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Gene PCR Primers product size Name ^ 
(bp) 
Forward: 5’-GGG AAG ATTAGTACC ACG GAT-3’ 
AC2 334 
Reverse: 5，-AGG AGAAGC CAA GGATGG ACG-3’ 
Forward: 5’-TGC TGC TGG TCA CCG TGC TCAT-3, 
AC6 495 
Reverse: 5'-GGA CGC TAA GCA GTA GAT CAT AGT TGT CAA-3' 
Forward: 5’-CAG TCT GGG CCT GAG GAAATT-3' 
ACS 478 
Reverse: 5’-AAG TCA GGT TCT TCAAGG GTA-3’ 
Forward: 5,-TAT GAC AAC TCCCTC AAG AT-3' 
GAPDH 317 
Reverse: 5’-AGATCC ACA ACG GATACATT-3' 




3.1 Characterization of prostanoid receptor expression in PC12 cells 
3.1.1 Study of the presence of Gq-coupled prostanoid receptors 
PLC-p is activated by Gq and leads to IP3 formation. Therefore, the presence of 
any Gq-coupled receptors in both undifferentiated and NGF-treated PC 12 cells can be 
determined by measuring the increase of [^H]1P production after incubation with 
various agonists, after pre-labelling cells with [^H]inositol. PGD2, PGE2 and PGF2a 
were used to activate DP, EP and FP receptors, respectively. In contrast, PGI2 and 
TXA2 are chemically unstable (Narumiya et al., 1999), therefore, their synthetic 
mimetics, cicaprost and U46619, were employed to lest for the presence of IP and TP 
receptors, respectively. Another five agonists were used to distinguish the EP 
receptor subtypes. Sulprostone is selective for the mouse EP3 receptors (Kj =0.6 nM), 
but also has considerable effect on the mouse EPl receptors (Kj =21 nM) (Narumiya 
et al., 1999)，and ONO-DI-004 is selective for the mouse EPl receptors (Kj =18 nM), 
ONO-AEI-259 is selective for the mouse EP2 receptors (Ki =3 nM), ONO-AE-248 is 
selective for the mouse EP3 receptors (Kj =7.5 nM), ONO-AEI-329 is selective for 
the mouse EP4 receptors (Kj =9.7 nM), and the Kj values of these four EP receptor 
agonists to others EP receptor subtypes are at least 100-fold greater than that of their 
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principal EP receptor (Suzawa et a l , 2000). The binding affinities of these agonists 
on their corresponding receptors which were represented by their inhibitory constant 
(Kj) values were at nanomolar concentrations. However, the agonist concentrations 
initially tested were much greater than their Kj values in order to achieve maximum 
receptor activation. 
In undifferentiated PC 12 cells cultured in complete culture medium, none of the 
prostanoid receptor agonists tested increased [^H]IP production (Fig. 3.1). In order to 
prove that the inability of these prostanoid receptor agonists to stimulate [^H]IP 
production was not due to the failure of the experimental setup, bradykinin and ATP 
were included as positive controls. Both bradykinin and ATP have been shown to 
increase ["Yl]lP production through the activation of the Gq-coupled bradykinin (B:) 
receptors and P2Y receptors in PC 12 cells, respectively (Graness et al., 1997; 
Moskvina et a l , 2003). The results show that bradykinin and ATP significantly 
increased [^H]IP production in undifferentiated PCI2 cells, to a level of 582 士 38o/o 
and 397 士 17% compared with control group, respectively (Fig. 3.1). 
In PC 12 cells treated with NGF for 32 h in low-serum medium, prostanoid 
receptor agonists were also unable to increase [^H]IP production (Fig. 3.2). In 
contrast, bradykinin and ATP significantly increased [^H]IP production in 
NGF-treated PC12 cells, to a level of 1412 士 38% and 644 ± 107% compared with 
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control group, respectively (Fig. 3.2). The [^H]IP production induced by bradykinin 
in NGF-treated PC 12 cells was significantly greater than that in undifferentiated 
PC12 cells (户<0.001). The ATP-induced [^H]IP production in NGF-treated PC12 
cells was also greater than that in undifferentiated PC 12 cells, but this effect was not 
statistically significant. 
These results suggest that Gq-coupled prostanoid receptors were not expressed 
in either undifferentiated or NGF-treated PC 12 cells. However, other Gq-coupled 
receptors such as B2 and P2Y receptors were found in PC 12 cells. 
3.1.2 Study of the presence of Gs-coupled prostanoid receptors 
All imAC are activated by Gs and subsequently catalyze the conversion of ATP 
to cAMP. Therefore, the presence of any Gs-coupled receptors in either 
undifferentiated or NGF-treated PC 12 cells can be determined by measuring the 
increase of [^HjcAMP production after incubation with various agonists, after 
pre-labelling cells with [^HJadenine. 
In undifferentiated PC 12 cells cultured in complete culture medium, none of the 
prostanoid receptor agonists tested increased [^HjcAMP production (Fig. 3.3). PC 12 
cells express Gs-coupled adenosine A2A receptors (Florio et al., 1999; Nie et al., 
1999), therefore, the selective A2A receptor agonist, CGS21680, was also tested as a 
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positive control. CGS21680 greatly increased the [^H]cAMP production by 388 士 
86% conversion compared with control group (Fig. 3.3). 
In PC 12 cells treated with NGF for 32 h in low-serum medium, prostanoid 
receptor agonists were also unable to increase [^H]cAMP production (Fig. 3.4), while 
CGS21680 significantly increased [^H]cAMP production in NGF-treated PC 12 cells 
by 298 土 32o/o conversion compared with control group, respectively (Fig. 3.4). 
Although the [-H]cAMP production induced by CGS21680 was slightly lowered in 
NGF-treated PC 12 cells, this difference was not statistically significant when 
compared with undifferentiated PC 12 cells. 
These results suggest that Gs-coupled prostanoid receptors were not expressed 
in either unditTereniiated or NGF-treated PC 12 cells. However, other Gs-coupled 
receptors such as A2a receptors were found in PC 12 cells. 
3.1.3 Study of the presence of Grcoupled prostanoid receptors 
The tmAC (except AC9) are directly activated by forskolin which dramatically 
increases the cellular cAMP level in different cell types (Insel & Ostrom，2003). On 
the contrary, cAMP level is lowered by Gj as it exerts an inhibitory effect on adenylyl 
cyclase. Therefore, the forskolin-stimulated cAMP production will be inhibited in the 
presence of activated Gj-coupled receptors. 
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In undifferentiated PC 12 cells cultured in complete culture medium, PGE2 
significantly inhibited the forskolin-stimulated [^H]cAMP production by 49.4 士 3.2o/o 
(P<0.01), suggesting the presence of Gj-coupled EP3 receptors (Fig. 3.5). Two EP3 
receptor agonists, sulprostone and ONO-AE-248, also inhibited forskolin-stimulated 
[-H]cAMP production by 29.8 士 2.5% and 14.7 土 Uo/。，respectively (P<0.01) (Fig. 
3.5). PGF2a also significantly inhibited forskolin-stimulated [^H]cAMP production 
by 23.7 土 4.10/0 (P<0.01)(Fig. 3.5). 
In PC 12 cells treated with NGF for 32 h in low-serum medium, only PGE2 and 
sulprostone could still generate a significant inhibition of forskolin-stimulated 
[•^H]cAMP production (厂<0.01) (Fig. 3.6). Moreover, the inhibition exerted by PGE：. 
PGF2u. ONO-AE-248 and sulprostone in NGF-treated PC 12 cells were all lower than 
that in untreated cells (Fig. 3.7)，but this was only statistically significant for PGE2 
(P<0.05). CGS21680 did not show any inhibition of the forskolin response in either 
cell types, confirming that activation of a classical Gs-coupled receptor does not 
inhibit forskolin-stimulated cAMP production. 
These results suggest that Gj-coupled EP3 receptors were expressed in both 
undifferentiated and NGF-treated PC 12 cells. PC 12 cells might also express 
Gj-coupled FP receptors, or PGF2a may be acting on EP3 receptors when tested here 
at 1 |iM (Ki =3 and 75 nM, for FP and EP3 receptor, respectively) (Narumiya et al.’ 
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1999). 
3.1.4 Further proof of EP3 expression in PC12 cells 
In order to confirm that the results of the assay of [^H]cAMP production in 
PC 12 cells was not affected by the endogenous production of prostanoids, the basal 
and the forskolin-stimulated [^HjcAMP production was determined in the presence 
of indomethacin, a non-selective COX inhibitor (Kawai, 1998). Results suggest that 
neither basal nor forskolin-stimulated ["HJcAMP production was affected by 
indomethacin in undifferentiated PC 12 cells (Fig. 3.8). 
Although PGE2 activates all four EP receptor subtypes, PGE2 was selected for 
the later study as EP3 receptors were the only possible subtype expressed in PC 12 
cells from the results of cAMP assay, and PGE2 exerted the greatest inhibitory 
response on forskolin-stimulated [^H]cAMP production among all the EP3 receptor 
agonists studied. 
The standard way to prove the existence of certain receptors is to perform a 
functional assay in the presence of the selective receptor antagonist. ONO-AE3-240 
was employed as the selective EPS receptor antagonist, with a K； value of 0.23 nM to 
EPS receptor, and the Kj values of this compound to other three EP receptor subtypes 
are at least 250-fold greater (Amano et al., 2003). ONO-AE3-240 inhibited the 
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PGE2-mediated inhibition of forskolin-stimulated [^H]cAMP production in PC 12 
cells in a dose-dependent manner (Fig. 3.9), and within the tested range, 
ONO-AE3-240 did not have any significant influence on basal or 
forskolin-stimulated [^HjcAMP production (Table 3.1). The PGE2-mediated 
inhibition of forskolin-stimulated [^HjcAMP production was almost completely 
blocked by ONO-AE3-240 at 10"^  M. These findings support our conclusion that 
PC 12 cells express Gj-coupled EP3 receptors. For additional confirmation, we could 
further prove the expression of Gj-coupled EP3 receptors in PC 12 cells by the 
addition of pertussis toxin (PTX), which can ADP-ribosylate and inactivate G, 
protein (Wu & Wong, 2005). Under these conditicns, the EP3 agonists should no 
longer inhibit forskolin-stimulated [^H]cAMP production. 
3.1.5 Discussion 
In this part of study, we aimed to characterize the prostanoid receptor expression 
profile in PC 12 cells by measuring the effect of different prostanoid receptor agonists 
on [^H]IP or [^H]cAMP production. Our results suggest that PC 12 cells do not appear 
to express DP, EPl, EP2, EP4, IP or TP receptors, as their selective agonists did not 
show any significant effect on [^H]IP or [^H]cAMP production. In contrast, PC 12 
cells definitely express EP3 receptor, and the evidence for FP receptor is more 
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controversial and will be discussed later. 
In undifferentiated PC 12 cells, PGE2 exerted greatest inhibition of 
forskolin-stimulated [^H]cAMP production among all the tested compounds, and the 
two other EP3 receptors agonist, sulprostone and ONO-AE-248, also inhibited 
forskolin-stimulated [^H]cAMP production. Moreover, the EP3 receptor antagonist, 
ONO-AE3-240, completely blocked the PGE2-mediated inhibition of 
forskolin-stimulated [^H]cAMP production. These findings indicate the presence of 
Gi-coiipled EP3 receptor in PC 12 cells, which is consistent with another study 
showing abundant expression of mRNA for EP3 receptor in PC 12 celis (Kitanaka et 
al., 1996). 
Although sulprostone has a considerable ability to activate EPl receptors 
(Narumiya et al., 1999)，it was logical to exclude the possible existence of 
Gj-coupled EPl receptor. First, the principal transduction of EPl receptors is through 
Gq, however, the selective EPl receptor agonist, ONO-DI-004, did not stimulate 
[^H]IP production, which did not support the presence of EPl receptor in PC 12 cells. 
Second, ONO-DI-004 only exerted a negligible effect on forskolin-stimulated 
[^H]cAMP production, therefore, it was unlikely that there was EPl receptors 
coupled to Gi. PGF2a also significantly inhibited forskolin-stimulated [^HjcAMP 
production, but it was possibly due to the cross activation of EP3 receptor by 1 |iM 
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concentration (Narumiya et a l , 1999). The principal transduction of FP receptor is 
through Gq, but PGF2a did not stimulate [^H]IP production, therefore, PC 12 cells 
were not likely to express FP receptors. Although a Gj-coupled FP receptor has been 
characterized in the rabbit kidney (Hebert et al., 2005), the study of mRNA 
expression suggested an absence of FP mRNA in PC 12 cells (Kitanaka et al., 1996). 
As a result, the existence of a Gj-coupled FP receptor in PC 12 cells was questionable. 
It is necessary to perform an antagonist study using ONO-AE3-240 to clarify any 
involvement of EP3 receptor response mediated by PGF�^, or using the FP receptor 
antagonist (e.g. AL-8810) to clarify the presence of FP receptor in PC 12 cells. 
NGF treatment induces changes of receptor responses in PC 12 cells. NGF 
caused a prominent increase in bradykinin-induced ["H]IP production in PCI2 cells 
after 32 h treatment. This increase of the bradykinin receptor response was consistent 
with the study showing that the number of B! receptors was increased by NGF in 
PC12 cells (Bush et al., 1991). The ATP-induced [^H]IP production was also slightly 
increased after NGF treatment, however, it was not statistically significant. NGF was 
found to suppress the mRNA expression of P2Y6 and P2Yii receptors in PC 12 cells 
after 72 h treatment, but had no effect on other P2Y receptor subtypes (Arthur et a l , 
2007). Therefore, it was not expected that there would be a significant change of the 
P2Y receptors expression and their responses after NGF treatment which is much 
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shorter than 72 h in our experiments. The [^H]cAMP production mediated through 
the activation of Aja receptors by CGS21680 was slightly decreased by NGF 
treatment in PC 12 cells, although it was not statistically significant. Our micro array 
data also suggested an 8.6-fold decrease of A2a mRNA expression after 12 h NGF 
treatment. The slight decrease of the A2A receptor response was possibly due to the 
NGF-induced down-regulation of A2A receptor expression (Arslan et al., 1997). 
So far, we have characterized the prostanoid receptor expression profile in 
NGF-treated PC 12 cells, and provided strong evidence to support the presence of 
Grcoupled EP3 receptors in PC 12 cells. The decrease of the EP3 receptor response 
in PC 12 cells might be due to the effects of NGF alone or the transfer of cells from 
high serum state to a lower serum state, and subsequent experiments were performed 
to find the explanation (see section 3.2). 
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Fig. 3.1. Undifferentiated PC12 ceils do not express Gq-coupled prostanoid 
receptors. PC 12 eel is v ere cultured in complete culture medium lor 48 h. AUer 
pre-labelling with [''HjinositoU PC12 cells were incubated with different prostanoid 
receptor agonists (1 |iM ), or bradykinin (10 |iM) or ATP (100 |iM) as the positive 
controls, for 1 h. Agonist-stimulated [^H]IP production has been normalized against 
the control within each experiment which was defined as 100%. Control [^H]IP 
production was 3.22 土 0.62. Results represent mean 土 S.E.M. of three independent 
experiments performed in triplicate. (**P<0.01, one-way ANOVA with Dunnett's 
post test.) 
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Fig. 3.2. NGF-treated PCI2 cells do not express G(】-coupled prostanoid 
receptors. PC 12 cells were treaied with NGF (50 iig/ml) for 32 h in low-serum 
medium. Alter pre-labelling with [.�H]inositol’ PC12 cells were incubated with 
different prostanoid receptor agonists (1 )，or bradykinin (10 |liM) or ATP (100 
|uM) as the positive controls, for 1 h. Agonist-stimulated [^H]IP production has been 
normalized against the control within each experiment which was defined as 100%. 
Control [^H]IP production was 3.27 ±0.31. Results represent mean 士 S.E.M. of three 
independent experiments performed in triplicate. (**P<0.01, one-way ANOVA with 
Dunnett's post test.) 
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Fig. 3.3. Undifferentiated PCI2 cells do not express Gs-coupled prostanoid 
receptors. PC 12 cells were cultured in complete culture medium for 48 h. After 
pre-labelling with ["H]adenine, PC 12 cells were incubated with different prostanoid 
receptor agonists (1 |aM) or the adenosine 八2八 receptor agonist, CGS21680 (1 ^M), 
as the positive control, for 30 min. Agonist-stimulated [^HjcAMP production has 
been normalized against the control within each experiment which was defined as 
100%. Control [^H]cAMP production was 0.070 士 0.005% conversion. Results 
represent mean 土 S.E.M. of four independent experiments performed in triplicate. 
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Fig. 3.4. NGF-treated PCI2 cells do not express Gs-coupled prostanoid receptors. 
PC 12 cells were treated with NGF (50 ng/ml) for 32 h in low-serum medium. After 
pre-labclling with ["'Hjadenine, PCI2 cells were incubated with different prostanoid 
receptor agonists (1 |.iM) or the adenosine Aia receptor agonist, CGS21680 (1 i^ M)， 
as the positive control, for 30 min. Agonist-stimulated [^H]cAMP production has 
been normalized against the control within each experiment which was defined as 
100%. Control [^H]cAMP production was 0.093 ± 0.011% conversion. Results 
represent mean 士 S.E.M. of four independent experiments performed in triplicate. 
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Fig. 3.5. Undifferentiated PCI2 cells express Gi-coupled prostanoid receptors. 
PC 12 cells were cultured in complete culture medium for 48 h. After pre-labelling 
with ["H]adenine, PC 12 cells were incubated with different prostanoid receptor 
agonists (1 or CGS21680 (1 |aM), in the presence of forskolin (1 |aM), for 30 
min. The forskolin-stimulated [^H]cAMP production of control was defined as 100%. 
Basal and forskolin-stimulated [^H]cAMP production was 0.070 土 0.005% and 0.426 
土 O.O590/0 conversion, respectively. Results represent mean 士 S.E.M. of four 
independent experiments performed in triplicate. (**P<0.01, one-way ANOVA with 
Dunnett's post test.) 
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Fig. 3.6. NGF-treated PC12 cells express GrCOupled prostanoid receptors. PCI2 
cells were treated with NGF (50 ng/ml) for 32 h in low-serum medium. After 
pre-label ling with ['Yl]adenine, PC 12 cells were incubated with different prostanoid 
receptor agonists (I |liM) or CGS21680 (1 |iM), in the presence of forskolin (1 |iM), 
for 30 min. The forskolin-stimulated [^H]cAMP production of control was defined as 
100%. Basal and forskolin-stimulated [^H]cAMP production was 0.093 士 O.OUo/o 
and 0.442 士 0.052% conversion, respectively. Results represent mean 土 S.E.M. of 
four independent experiments performed in triplicate. (**P<0.01, one-way ANOVA 
with Dunnett's post test.) 
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Fig. 3.7. Comparison of inhibition of forskolin-stimulated [^H]cAMP production 
mediated by P G E 2 , PGF2«, ONO - A E-248 or sulprostone in undifferentiated and 
NGF-treated PCI2 cells. PC 12 cells were either cultured in complete culture 
medium for 48 h (undifferentiated) or treated with NGF (50 ng/ml) for 32 h in 
low-serum medium. Values are mean 土 S.E.M. of four independent experiments. 
(**P<0.01, two-way ANOVAwith BonfeiToni post test.) 
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Fig. 3.8. Indomethacin ( C O X inhibitor) did not affect the basal or 
forskolin-stimulated [^HjcAMP production in untreated PC12 cells. PC12 cells 
were cultured in complete culture medium for 48 h. After pre-labelling with 
[">I]adenine, PC 12 cells were incubated with HBS or forskolin (1 )uM) in the 
presence or ；absence of indomethacin (3 uM) for 30 min. Results represent mean 土 
S.D., from one experiment performed in duplicate. 
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Fig. 3.9. The effect of ONO-AE3-240 (EP3 receptor antagonist) on 
PGE2-niediated inhibition of forskolin-stimulated [^H]cAMP production in 
untreated PCI2 cells. PC 12 cells were cultured in low-serum medium and the assay 
was performed on Day 0. Cells were pre-treated with different concentrations of 
ONO-AE3-240 for 30 min, then incubated with HBS or PGE2 (1 |iM) in the presence 
or absence of forskolin (1 |aM) for another 30 min. Each data point represent mean 士 
S.E.M. of two to three independent experiments performed in duplicate or triplicate. 
Basal and forskolin-stimulated [^H]cAMP production at various concentration of 
O N O - A E 3 - 2 4 0 are listed in Table 3.1. 
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[^H]cAMP production 
[ONO-AE3-240] (M) Basal (% conversion) Forskolin (% conversion) 
0 0 . 0 7 2 士 0 . 0 1 5 0 . 2 7 2 土 0 . 1 9 8 
10-9 0 . 0 6 4 士 0 . 0 0 1 0 . 2 2 8 土 0 . 1 7 1 
10-8 0 . 0 5 0 士 0 . 0 2 6 0 . 2 4 0 土 0 . 1 3 9 
10-7 0 . 0 9 5 士 0 . 0 5 3 0 . 1 6 7 ± 0 . 0 7 0 
10-6 0.055 ± 0.033 0.174 土 0.061 
Table 3.1. Effect of ONO-AE3-240 on basal and forskolin-stimulated [^HlcAMP 
production of undifferentiated PC12 cells. Values of basal and forskolin-stimulated 
[-^H]cAMP production al various concentration of ONO-AE3-240 in Fig. 3.9 are 
listed. ONO-AE3-240 did not affect the basal or forskolin-stimulated [-H]cAMP 
production within the tested range. (Data analyzed with one-way ANOVA with 
Bunferroni post test.) 
> 
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3.2 Time course effect of N G F on PCI 2 cells 
3.2.1 Effect of N G F on PGEz-mediated inhibition of forskolin-stimulated 
[^H]cAMP production 
In section 3.1, we have demonstrated that Gj-coupled EP3 receptors were 
expressed in both undifferentiated and NGF-treated PC 12 cells, as the EP3 receptor 
agonists were able to suppress the forskolin-stimulated [^HjcAMP production. In 
addition, we noted that the inhibitory effect exerted by these EP3 agonists appeared 
to be lower in PC 12 cells treated with NGF. We therefore made a hypothesis that the 
decrease of EPS receptor response was caused by the NGF treatment. However, 
undifferentiated PC 12 cells were normally maintained in complete culture medium 
which was supplemented with high content of serum, while PC 12 cells were 
transferred from high serum-containing medium to a medium with reduced serum 
supply during NGF treatment. Therefore, the change of the culturing conditions 
might also be responsible for the change of EP3 receptor response in PC 12 cells. In 
this part of study, we aim to determine the time-dependent effect of NGF on 
PGE2-mediated inhibition of forskolin-stimulated [^H]cAMP production in PC 12 
cells maintained in culture medium with either high or low serum supply over 6 days 
treatment. 
In PC 12 cells cultured in complete culture medium, the PGE2-mediated 
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inhibition of forskolin-stimulated [^HjcAMP production of control group was 
increased from about 20% to 60% after 12 h, then decreased gradually to day 2 and 
maintained steady to day 4, and the inhibition was almost completely lost on day 6 
(Fig. 3.10). For the NGF-treated group, the PGE2-mediated inhibition of 
forskolin-stimulated [^HjcAMP production was unchanged from day 0 to day 4, and 
the levels of inhibition were slightly lower than the control group during this period 
(Fig. 3.10). However, an unexpected increase of the PGE2-iTiediated inhibition of 
forskolin response was observed on day 6 in the NGF-treated group (Fig. 3.10). 
Unfortunately, the variation of the data was large and it is difficult to draw any clear 
conclusion showing that NGF is responsible for the decrease of PGE2-mediated 
inhibition on forskolin response. The PGE2-mediated inhibition of 
forskolin-stimulated [^H]cAMP production was calculated using four values, they 
were the [^H]cAMP production values of HBS or PGE2 in the presence or absence of 
forskolin, variation of any of the four values would cause large variation of the 
calculated inhibitory response. 
In PC 12 cells cultured in low-serum medium, the PGE2-mediated inhibition of 
forskolin-stimulated [^H]cAMP production of control group was decreased gradually 
from about 45% on day 0 to about 20% on day 6 (Fig. 3.11). For the NGF-treated 
group, the PGE2-mediated inhibition of forskolin-stimulated [^H]cAMP production 
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was more or less the same as the control group (Fig. 3.11). Therefore, NGF appeared 
not to influence the EP3 receptor response, and both the control and NGF-treated 
groups showed a similar decreasing trend of PGE2-mediated inhibition of 
forskolin-stimulated [^H]cAMP production, as a result, the apparent decrease of EP3 
receptor response observed in section 3.1 might possibly be due to the reduced serum 
supply to PC 12 cells after 32 h incubation. 
3.2.2 Effect of N G F on basal and forskolin-stimulated (^H]cAMP production 
Although NGF appeared not to influence the EP3 receptor response over 6 days 
t rea tment ,�ve noticed that NGF did affect the basal and forskolin-stimulated 
[^HJcAMP production within this time course. In control PC 12 cells cultured in 
complete culture medium, the basal [^H]cAMP production remained low from day 0 
to day 2, then it showed an increasing trend to day 6 (Fig. 3.12). Upon stimulation 
with forskolin, the [^H]cAMP production was increased, however, there was no 
significant difference between the basal and forskolin-stimulated [^H]cAMP 
production from day 0 to day 2. In contrast, the level of forskolin-stimulated 
[^H]cAMP production was significantly higher than the basal from day 4 to day 6 
(Fig. 3.12). For the NGF-treated group, the basal [^H]cAMP production was identical 
to that of control group (Fig. 3.12). The forskolin-stimulated [^H]cAMP production 
67 
of the NGF-treated group followed a similar trend as the control group, and was 
significantly higher than the basal on day 4 and day 6 (Fig. 3.12). Moreover, a 
striking effect was observed on day 4，showing that the NGF-treated group had a 
much greater forskolin-stimulated [^HjcAMP production than the control group, and 
it remained higher on day 6, though the difference was no longer statistically 
significant (Fig. 3.12). 
In control PC 12 cells cultured in low-serum medium, the basal ["^H]cAMP 
production remained low from day 0 to day 6 (Fig. 3.13). Forskolin increased the 
[^H]cAMP production in control group, however, there was no significant difference 
between the basal and forskolin-stimulated ['H]cAMP production from day 0 to day 
6 (Fig. 3.13). For the NGF-treated group, the basal [^H]cAMP production was similar 
to the control group (Fig. 3.13). The forskolin-stimulated [^H]cAMP production of 
the NGF-treated group was significant higher than the basal on day 4 and day 6 (Fig. 
3.13). In addition, the forskolin-stimulated [^HjcAMP production of the NGF-treated 
group was significantly greater than that of control group (Fig. 3.13). 
PC 12 cells behaved slightly differently in high-serum conditions compared with 
low-serum condition. For the control PC 12 cells, the basal and forskolin-stimulated 
[^H]cAMP production were similar in either high- or low-serum condition from day 
0 to day 4, but these responses were significantly higher for cells maintained in 
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high-serum condition on day 6 (Fig. 3.14). Basal [^H]cAMP production of 
NGF-treated PC 12 cells was also significantly higher when cells were maintained in 
high-serum condition on day 6 (Fig. 3.15). Moreover, forskolin-stimulated 
[^H]cAMP production of NGF-treated PC 12 cells in high-serum condition was 
slightly higher than that in low-serum condition on day 4 and day 6 (Fig. 3.15). One 
of the possible explanations is gene transcription responsible for cAMP production, 
such as AC, is suppressed in low-serum condition. Therefore, PC 12 cells tend to 
have a greater basal and forskolin-stimulated [^H]cAMP production when maintained 
in high-semm condition. 
The enhanced forskolin response in NGF-treated PC 12 cells might due to the 
survival promoting effect of NGF. Therefore, the viability of PC 12 cells maintained 
in low-serum medium on day 6 was determined by trypan blue exclusion test. There 
was no significant difference in the total number of cells between control and 
NGF-treated group, either before or after 30 min incubation with HBS or forskolin 
(Fig. 3.14A). Moreover, before the incubation with HBS or forskolin, the percentage 
of viable cells in both the control and NGF-treated group was over 90%, and 
forskolin did not influence the cell viability after 30 min incubation (Fig. 3.14B). 
Therefore, we can exclude the possibility that NGF enhanced forskolin response by 
promoting survival of PC 12 cells. 
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To summarize the above results, it is obvious that NGF did not have any 
significant effect on the basal [^H]cAMP production, but can dramatically augment 
the forskolin-stimulated [^H]cAMP production of PC12 cells in either high or low 
serum conditions. Interestingly, as the enhanced forskolin response was only 
observed after a long NGF treatment, it might be due to the regulation of gene 
transcription and protein expression by NGF in PCI2 cells (Gunning et al., 1981a). 
For example, NGF might promote the gene and protein expression of AC and lead to 
an enhanced forskolin-stimulated [^H]cAMP production of PC 12 cells, and the gene 
expression of AC will be discussed in section 3.2.5. 
3.2.3 Acute effect of N G F on [^HjcAMP production 
In control PC 12 cells cultured in low-serum medium on day 0, the 30 min 
incubation with NGF did not directly stimulate [^H]cAMP production, and did not 
enhance forskolin-stimulated [^H]cAMP production (Fig. 3.17A). Similar 
observations were obtained for control or NGF-treated PC 12 cells on day 6 (Fig. 
3 .17B&C) . 
NGF alone did not stimulate AC directly through the activation of its receptor. 
Also, NGF did not augment the forskolin response acutely. These results further 
suggest that the enhanced forskolin-stimulated [^H]cAMP production of NGF-treated 
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PC12 cells in section 3.2.2 was caused by the chronic effect of NGF on gene and 
protein expression. 
3.2.4 Effect of N G F withdrawal on basal and forskolin-stimulated [^HJcAMP 
production 
We have demonstrated that a chronic treatment of PC 12 cells with NGF could 
enhance forskolin-stimulated [^H]cAMP production, and in this part of study, we aim 
to determine if a continued supply of NGF is necessary to maintain the enhanced 
forskolin response. In addition to a continued treatment with NGF over 6 days, NGF 
was removed on day 2 or day 4 to determine the effect of NGF withdrawal on the 
forskolin-stimulated ["^H]cAMP production in PC 12 cells maintained in low-serum 
medium. 
A consistent observation was obtained as before, the forskolin-stimulated 
[^H]cAMP production of control and NGF-treated group increased from day 0 to day 
6, with NGF-treated group having a significantly higher [^H]cAMP production than 
control group on day 4 and day 6 (Fig. 3.18). When NGF was removed on day 2, 
there was no subsequent enhanced response of PC 12 cells to forskolin on day 4, and 
the forskolin-stimulated [^H]cAMP production ended up at a similar level as the 
control group on day 6 (Fig. 3.18). In contrast, the enhanced response to forskolin 
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was maintained on day 6 when NGF was removed on day 4 (Fig. 3.18). 
We hypothesized that chronic NGF is required to promote gene expression 
responsible for the increase of forskolin response in PC 12 cells, and it is a delayed 
response as the enhanced forskolin response was first observed after 4 days NGF 
treatment. Also, the initiation of expression of those genes are dependent on NGF but 
become independent of NGF at the later stage, as noted by the persistent enhanced 
forskolin response after 4 days NGF treatment but not after just 2 days NGF 
treatment. 
3.2.5 Effect of N G F on adenylyl cyclase gene expression 
We hypothesized that an increase of AC expression is one of the possible 
explanations to account for the enhanced forskolin-stimulated [^H]cAMP production 
triggered by NGF in PC 12 cells. As mentioned in section 1.8, AC is divided into 
Group I to Group IV, and Group IV AC is not sensitive to forskolin (Simonds, 1999). 
We have performed a preliminary study on how NGF affected the mRNA expression 
of AC2, AC6 and ACS (representative members of Group II，I and III AC, 
respectively) in PC 12 cells by RT-PCR. 
We found that only AC6 mRNA was expressed in either control or NGF-treated 
PC 12 cells as signal was detected at 495 bp (Fig. 3.19). In order to prove that the 
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absence of AC2 and ACS expression in PC 12 cells was not due to a problem with the 
primers, rat brain tissue was used as the positive control because they express AC2, 
AC6 and ACS (Delmeire et al., 2003). Signals corresponding to all the three AC 
isoforms were detected in rat brain tissue, which confirmed that AC2 and ACS were 
really absent in PC12 cells (Fig. 3.19). 
To study the change of AC6 mRNA expression in PC 12 cells, signals of AC6 
expression was normalized againsi the signals of GAPDH. The AC6 mRNA 
expression remained stable from day 0 to day 6 (Fig. 3.20A). However, A6 mRNA 
expression was up-regulated after 2 days NGF treatment, but returned to control level 
on day 4 and then slightly decreased on day 6 (Fig. 3.20A). When NGF was removed 
oil day 2, the degree of decrease of AC6 mRNA expression was smaller than the 
NGF-treated group on day 4, and ended up at a similar level as the control group (Fig. 
3.20A). In contrast, the down-regulation of AC6 mRNA expression was maintained 
on day 6 when NGF was removed on day 4 (Fig. 3.20A). We also expressed the 
above data without normalized against the signals of GAPDH, and NGF did not 
up-regulate AC6 expression on day 2, but still down-regulate AC6 expression on day 
4 and day 6 (Fig. 3.20B). However, as the intensity of signal depends on the 
exposure time, it is more appropriate to express the data with normalized against the 
signals of GAPDH. 
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These results appear to contradict to our hypothesis. However, this is only a 
preliminary study so it is better not to overweight on the data. Also, the other AC 
isoforms might be up-regulated instead of AC6 by NGF in PC 12 cells to account for 
the enhanced forskolin-stimulated [^H]cAMP production. We will therefore have to 
investigate the expression of all AC isoforms before coming to any definite 
conclusion. 
3.2.6 Discussion 
We found that NGF appeared not to change the degree of EP3 receptor response 
in PC 12 cells maintained in high- or low-serum containing medium over 6 days 
treatment. However, we noticed that the forskolin-stimulated ['H]cAMP production 
was increased in both control and NGF-treated PC 12 cells cultured in high or low 
serum condition over 6 days treatment, and the NGF-treated group appeared to 
increase to a greater extent. As a result, it might be more difficult for PGE2 to inhibit 
forskolin-stimulated [^H]cAMP production at the later stage of this experiment. 
Since the forskolin-stimulated [^HjcAMP production was different in the control and 
NGF-treated group, there is limitation using this experimental setup to determine the 
change of EP3 receptor response caused by NGF and we have to be conservative 
when interpreting these results. Perhaps, the radioligand receptor binding assay 
74 
using [^H]PGE2 is a better approach to study the effect of NGF on EP3 receptor 
expression in PC 12 cells. 
We also demonstrated that NGF did not induce [^H]cAMP production directly 
I 
through the activation of its receptors in PC 12 cells, as short term treatment with 
NGF did not affect the basal or forskolin-stimulated [^H]cAMP production. 
Moreover, there was no significant difference of forskolin-stimulated [^HJcAMP 
prcduction between comrol and NGF-treated cells from day 0 to day 2, but the 
response was significantly higher in NGF-treated cells from day 4 to day 6. 
Therefore, chronic NGF treatment enhanced forskolin-stimulated ["HjcAMP 
production probably through the induction of AC expression, because the enhanced 
forskolin response was persistent alter 4 days NGF treatment but not after 2 days 
NGF treatment. We speculated that the initiation of increase of AC expression in 
PC 12 cells was dependent on NGF, however the maintenance of AC level became 
NGF-independent, provided that cells had received more than 2 days of NGF 
treatment. 
Finally, we were able to detect AC6 in PC 12 cells, but AC2 and ACS were 
absent. Although the change of AC6 expression did not match with the time course of 
enhanced forskolin-stimulated [^H]cAMP production, as AC6 expression was not 
up-regulated in NGF-treated PC 12 cells on day 4 and day 6, the enhanced 
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forskolin-stimulated [^H]cAMP production might be related to the change of other 
AC isoforms. 
To summarize this part of study, we have demonstrated that chronic NGF 
treatment increased [^H]cAMP production of PC 12 cells possibly by increasing AC 
expression. The importance of elevating cAMP production in differentiation of PC 12 
cells will require further study. 
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Fig. 3.10. The change of PGE2-mediated inhibition of forskolin-stimulated 
|^H]cAMP production by PCI2 cells maintained in complete culture medium. 
PCI2 cells were maintained in complete culture medium (士 NGF，50 ng/ml) over 6 
chiys, and medium (士 NGF) renewed every 2 days. After pre-labelling with 
['H]adenine, PC 12 cells were incubated with HBS or PGE2 (1 |iM) in the presence or 
absence of forskolin (1 ).iM) for 30 min. The forskolin-stimulated [^H]cAMP 
production in control or NGF-treated cells treated with HBS only was defined as 
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Fig. 3.11. The change of PGEz-mediated inhibition of forskolin-stimulated 
[^HJcAMP production by PC12 ceils maintained in lo、v-serum medium. PC12 
cells were maintained in low-serum medium (士 NGF, 50 ng/ml) over 6 days, and 
medium (土 NGF) renewed every 2 days. After pre-labelling with ["H]adenine, 
PC 12 cells were incubated with HBS or PGE2 (1 in the presence or absence of 
forskolin (1 |iM) for 30 min. The forskolin-stimulated [^H]cAMP production in 
control or NGF-treated cells treated with HBS only was defined as 100%. Results 
represent mean 士 S.E.M. of three independent experiments performed in duplicate. 
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Fig. 3.12. The effect of N G F on basal and forskolin-stimulated [^HjcAMP 
production by PC12 cells maintained in complete culture medium. Data obtained 
from Fig. 3.10. (Data analyzed with two-way ANOVA with Bonferroni post test. 
***P<0.001, compared with forskolin-rcsponse of control group. ###P<0.001, 
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Fig. 3.13. The effect of N G F on basal and forskolin-stimulated [^HlcAMP 
production of P C 12 cells maintained in low-serum medium. Data obtained from 
Fig. 3.11. (Data analyzed with two-way AN OVA with Bonferroni post test. 
"*p<0 .001 , compared with forskolin-response of control group. ###P<0.001, 
compared with basal of NGF group.) 
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Fig. 3.14. Comparison of basal and forskolin-stimulated (^HJcAMP production 
of control PC12 cells maintained in complete culture m e d i u m or low-serum 
medium. Data obtained from Fig. 3.10 and 3.11. (A) Basal [^H]cAMP production. 
(B) Forskolin-stimulated [^HjcAMP production. (***P<0.001, two-way ANOVA 
with Bonferroni post test.) 
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Fig. 3.15. Comparison of basal and forskolin-stimulated [^HlcAMP production 
of NGF-treated PC12 cells maintained in complete culture medium or 
low-serum medium. Data obtained from Fig. 3.10 and 3.11. (A) Basal [^HjcAMP 
production. (B) Forskolin-stimulated [^H]cAMP production. (***P<0.001, two-way 




liP 「 I T pS- CZ3 Control 
° A J L mm NGF 
丨 L L l 
/ </ / Z , / 
(B) 
100-
n B n r ^ • Control 
I l l _ N。 F • • • 
LLl 
o J — J _ I j ^ L f ^ m L p ^ / f 
力 , / 
Fig. 3.16. Characteristics of PC12 cells on Day 6 as used in c A M P assay. PC12 
cells were maintained in low-serum medium (士 NGF, 50 ng/ml) for 6 days, and 
medium (士 NGF) renewed every 2 days. (A) Total cell number was counted with 
hemocylometer and (B) the cell viability was determined by trypan blue exclusion 
test, before and after incubation with HBS or forskolin (1 |iM) for 30 min. Results 
represent mean 土 S.E.M.，from one experiment performed in triplicate. 
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Fig. 3.17. Acute addition of N G F did not stimulate [^HlcAMP production by 
P C I 2 cells. PC 12 cells were maintained in low-serum medium (士 NGF, 50 ng/ml), 
and medium renewed every 2 days. During the assay, cells were incubated with HBS 
or NGF (50 ng/ml) in the presence or absence of forskolin (1 ^iM) for 30 min. (A) 
Control cells on Day 0，(B) Control cells on Day 6，(C) NGF-treated cells on Day 6. 
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Fig. 3.18. The effect of N G F withdrawal on forskolin-stimulated (^HJcAMP 
production by PCI2 cells. PC 12 cells were maintained in low-serum medium (士 
NGF, 50 ng/ml). For the NGF withdrawal groups, medium containing NGF was 
removed and replaced with low-serum medium for the later period. Medium (士 NGF) 
were renewed every 2 days. Results represent mean 士 S.E.M. of three independent 
experiments performed in duplicate. (Data analyzed with two-way ANOVA with 
Bonferroni post test. **P<0.01, ***P<0.001, compared with control group. 
###P<0.001, compared with NGF group.) 
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Fig 3.19. Expression of AC m R N A in PC12 cells. PC12 cells were maintained in 
low-serum medium (士 NGF, 50 ng/ml). For the NGF withdrawal groups, medium 
containing NGF was removed and replaced with low-serum medium for the later 
period. Medium (士 NGF) were renewed every 2 days. At specific time points, total 
RNA was extracted using Trizol reagent. The expression of AC was performed by 
RT-PCR, with GAPDH as the internal control. The RT-PCR products were resolved 
by electrophoresis in 2.2% agarose gel and visualized by ethidiuin bromide staining 
and subsequent UV illumination. Rat brain tissue was used as positive control, and 
the expected RT-PCR products sizes of AC2, AC6, ACS and GAPDH were 334, 495， 
478 and 317 bp, respectively. 
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Fig 3.20. Expression of A C 6 m R N A in PC12 cells. The band intensity of A C 6 and 
G A P D H products were analyzed by Scion Image. The A C 6 m R N A expression is 
expressed (A) relative to the level of G A P D H m R N A or (B) as the raw densitometry 
reading. Results come from one experiment. 
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3.3 Quantification of the degree of differentiation of PCI 2 cells 
3.3.1 Expression of neurofilament protein as a marker of differentiation 
Neurofilaments are the major intermediate filament cytoskeletal networks of 
neurons (Lee et al., 1993; Brownlees et al., 2000), and are composed of a light 
subunit (NfL)，medium siibunit (NfM), and heavy subiinit (NfH), with molecular 
weight around 68, 150 and 200 kDa, respectively (Elder et al., 1998). NGF was 
found to promote NfH protein expression in PC 12 cells in a time-dependent manner 
(Liu et a l , 2006). Therefore, the measurement of NfH expression would be a 
possible approach to quantify the degree of differentiation of PC 12 cells. 
The NfH protein expression showed a dose-dependent increase in NGF-treated 
cells after 4 days, with the greatest expression at 50 ng/ml of NGF (Fig. 3.21 A). The 
NfH protein expression increased after 1 day NGF treatment (50 ng/ml), but the 
expression was not increased further afterward (Fig. 3.2IB). When PC 12 cells were 
treated with various concentrations of NGF for longer periods, we could not observe 
an obvious trend showing that the NfH protein expression was correlated to NGF 
exposure (Fig. 3.22). As a result, it is difficult to employ the measurement of NfH 
expression to quantify the degree of differentiation of PC 12 cells in our system. 
89 
3.3.2 Neurite assays 
Since the use of neurofilament protein expression as the marker of neuronal cell 
differentiation was not so successful, we adopted another method to quantify 
differentiation. A typical method to assess differentiation is by counting the number 
of cells extending neurites of lengths more than one cell diameter or by direct 
measurement of neurite length. We have performed this assay using two approaches, 
by manual assessment of PC 12 cells under the observation of microscope and 
quantification of the captured cell images. In order to obtain clear images of PC 12 
cells without overcrowding, cells were plated at low density (5 x lO^ cells/well) in 
6-well plates. 
3.3.2.1 Manual assessment of PC12 cells 
The proportion of PC 12 cells expressing neurites of length more than one cell 
diameter was determined over 14 days NGF treatment. As expected, the proportion 
of PC 12 cells expressing neurites of the control group over the treatment period 
remained low at not more than 3% (Fig. 3.23). In contrast, the proportion of cells 
expressing neurites in the NGF-treated group increased in a time-dependent manner 
(Fig. 3.23). The results confirmed that NGF can promote differentiation of PC 12 
cells as expected (Perry et al., 2002; Attiah et al., 2003; Cappelletti et al., 2007). 
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However, there are at least two limitations of this assay. First, the manual assessment 
might be too subjective and is time-consuming (take about 20 min for each plate), 
cells have to be exposed to an environment which is unfavorable for their growth, 
including the drop of temperature and carbon dioxide content. Second, we cannot 
measure multiple parameters at the same time. We can only count the number of 
neurite-expressing cells at each time point, but cannot quantify the length of neurites, 
so we cannot get a comprehensive representation of the differentiation of PC 12 cells. 
3.3.2.2 Quantification of images of PC12 cells 
Due to the limitation of the manual assessment method, we employed another 
method to quantify differentiation of PC 12 cells. With the aid of a digital image 
capturing system, random fields of cells can be captured and analyzed later, which 
helps to minimize the exposure time of the cells in unfavorable environment. Also, it 
is possible to measure multiple parameters of the same group of cells. The captured 
cell images of control and NGF-treated PC 12 cells were shown in Fig. 3.24. 
We have studied the effect of NGF and its withdrawal on the neurite expression 
of PC 12 cells. In our experiment, the control group did not appear to express neurites, 
while the NGF-treated group showed an increase in proportion of cells expressing 
neurites in a time-dependent manner, and about 80% of cells expressed neurites after 
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6 days treatment (Fig. 3.25), which implied that this method was more sensitive than 
the manual assessment of PC 12 cells as only about 30% of cells expressed neurites 
after 6 days treatment using the latter method (Fig. 3.23). When NGF was removed 
on either day 2 or day 4, both groups showed a decrease in proportion of cells 
expressing neurites (Fig. 3.25). The average length of the longest neurite was also 
quantified. NGF significantly increased the neurite length after 2 days, and the 
neurite length increased in a time-dependent manner afterwards (Fig. 3.26). The 
neurite length decreased when NGF was removed on either day 2 or day 4 (Fig. 3.26). 
A similar pattern was observed when measuring the number of neurites expressed by 
PC 12 cells (Fig. 3.27). The quantifications of the above three parameters were 
consistent with the reported founding showed that neurite stability of PC12 cells was 
decreased after removal of NGF (Attiah et a l , 2003). In summary, we have 
demonstrated that NGF can promote differentiation of PC 12 cells revealed by the 
increased proportion of neurite-expressing cells, increased length of neurite, and the 
increased average number of neurite expression. Also, the continual presence of NGF 
is required to maintain the existence of neurites in PC 12 cells. 
Several studies have reported that in PCI2 cells stably expressing EP3B 
receptor isoform isolated from bovine adrenal chromaffin cells, treatment with EP3 
receptor agonist of the NGF-treated cells can induce neurite retraction through a 
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PTX-insensitive pathway (Katoh et al., 1996; Katoh et al., 1998a; Aoki et al., 1999). 
Therefore, we hypothesized that PGE2 might attenuate NGF-induced neurite 
outgrowth of PC12 cells. Conversely, blocking EP3 receptors with ONO-AE3-240 
might enhance the NGF-induced neurite outgrowth of PC 12 cells. The results 
suggested that treatment with PGE2 alone, ONO-AE3-240 alone, or combination of 
these two compounds did not affect the proportion of neurite-expressing cells (Fig. 
3.28) or the average length of longest neurite (Fig. 3.29). Neither treatment with 
PGE2 alone, nor ONO-AE3-240 alone affected the average number of neurite 
expression of PC 12 cells, however, it was not expected that the co-treatment of these 
two compounds could increase the average number of neurite expression (Fig. 3.30). 
3.3.3 Discussion 
In this part of study, we have established a proper method to quantify the 
differentiation of PC 12 cells. The measurement of NfH protein expression is perhaps 
a more objective and less labor-intensive method than the neurite assay, however, it 
is only semi-quantitative, and due to the minimal induction of NfH protein 
expression by NGF in PC 12 cells which limited the sensitivity of this assay, we 
failed to adopt the measurement of NfH protein expression as the marker of 
differentiation. 
93 
The manual assessment of PC 12 cells appeared to be less sensitive than 
quantification of cell images, as the proportion of cells classified as 
neurite-expressing in the later method was much greater than the former method. The 
reason might be due to the estimation of cell diameter and neurite length by manual 
observation. Therefore, the degree of differentiation determined by quantification of 
cells images of PC 12 cell was considered as the best method in our study. 
The results suggest that NGF can promote differentiation of PC 12 cells by 
increasing the proportion of neurite-expressing cells, length of neurite, and the 
average number of neurite expression, and these three parameters showed a 
decreasing trend no matter when NGF was removed. In contrast, in section 3.2.4, we 
found that the enhanced forskolin-stimulated [^H]cAMP production was maintained 
when NGF was removed on day 4 but not on day 2, suggesting that cAMP was not 
related to the maintenance of the stability of neurites. Therefore, NGF is 
indispensable for the maintenance of neurites of PC 12 cells through a 
cAMP-independent manner. 
We have showed that NGF did not regulate the EP3 receptor expression in PC 12 
cells in section 3.2.1, we also demonstrated that neither activations of EP3 receptors 
using PGE2 nor blocking EP3 receptors using ONO-AE3-240 could influence 
NGF-induced neurite outgrowth. This finding suggested that EP3 receptors are not 
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directly participating in the regulation of neurite outgrowth of NGF-treated PC 12 
cells. However, EPS receptors might play other functional roles in PC 12 cells, for 
example, the dopamine release was inhibited in PC 12 cells by the activation of EP3 
receptors (Nakamura et al., 1998). In summary, we have employed the neurite assay 
to monitor the degree of differentiation of PC12 cells and proved that the continual 
presence of NGF is required to maintain the stability of neurites in PC 12 cells. And 
this approach can also be used to study the effect of other compounds which may 
influence NGF-induced differentiation of PC 12 cells, as we found that neither PGE2 
nor ONO-AE3-240 could change the degree of NGF-induced differentiation of PC 12 
cells. 
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Fig. 3.21. Expression of neurofilament heavy chain (NfH) protein in PC12 cells. 
PC 12 cells were maintained in low-serum medium and treated with (A) 0, 1,5, 10 
or 50 ng/ml NGF for 4 days or (B) 50 ng/ml NGF for 0 to 4 days. NGF and medium 
were renewed every 2 days. At the specific time, total protein was extracted and the 
protein concentration was determined by protein assay. Equal amount of protein (20 
|ig) of each sample were loaded onto 6% SDS-PAGE gel. The band intensities were 
determined by Scion Image. The NfH level was expressed as fold of increase of 
control (samples without NGF in (A) and at time zero in (B) were defined as 
control). Results come from one experiment. 
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Fig. 3.22. Effect of N G F on N f H protein expression in PC12 cells. PC12 cells 
were maintained in low-serum medium and treated with 0，1, 5, 10 or 50 ng/ml NGF 
for 4, 7 or 10 days. NGF and medium were renewed every 2 days. At the specific 
time, total protein was extracted and the protein concentration was determined by 
protein assay. Equal amount of protein (20 |Lig) of each sample were loaded onto 6% 
S D S - P A G E gel. The band intensities were determined by Scion Image. The NfH 
level was expressed as fold of increase of control (samples without NGF were 
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Fig. 3.23. Manual assessment of neurites expression by PC12 cells. P C 12 cells 
were maintained in low-serum medium (土 NGF, 50 ng/ml), and medium was 
renewed every 2 days. At specific time points, 100 cells per well were quantified 
under microscopic observation. Cells were considered as expressing neurites with 
neurite greater than one cell body in length. Results represent mean 士 S.E.M. of three 
independent experiments performed in triplicate. (Data analyzed with two-way 




Fig. 3.24. Images ot PC12 cells captured by digital camera. Images presented 
were corresponding to Fig. 3.25. (A) Control cells on Day 0, (B) NGF-treated cells 
on day 2，(C) on day 4，and (D) on day 6. 
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Fig. 3.25. The effect of N G F and its withdrawal on the number of PC12 cells 
expressing neurites. P C 12 cells were maintained in low-serum medium (士 NGF, 50 
ng/ml). For the NGF withdrawal groups, medium containing NGF was removed and 
replaced with low-serum medium for the later period. Medium (± NGF) were 
renewed every 2 days. At specific time points, images were captured and 100 cells 
were quantified for each well. Cells were considered as expressing neurite with 
neurite greater than one cell body in length. Results represent mean 士 S.E.M., from 
six independent wells and two independent experiments. (Data analyzed with 
two-way ANOVA with BonfeiToni post test. ***P<0.001, compared with control 
group. ###P<0.001, compared with N G F group.) 
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Fig. 3.26. The effect of N G F and its withdrawal on the length of neurites of 
PCI2 cells. P C 12 cells were maintained in low-serum medium (土 N G F , 50 ng/ml). 
For the NGF withdrawal groups, medium containing NGF was removed and replaced 
with low-serum medium for the later period. Medium (士 NGF) were renewed every 2 
days. At specific time points, images were captured and 100 cells were quantified for 
each well. Cells were considered as expressing neurite with neurite greater than one 
cell body in length. Lengths of longest neurite of neurite-possessing cells were 
measured. Results represent mean 士 S.E.M.，from six independent wells and two 
independent experiments. (Data analyzed with two-way ANOVA with Bonferroni 
post test. **P<0.001, ***尸<0.001’ compared with control group. #P<0.05, ##P<0.01， 
###P<0.001, compared with N G F group.) 
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Fig. 3.27. The effect of N G F and its withdrawal on the number of neurites 
expressed by P C 12 cells. PC 12 cells were maintained in low-serum medium (士 NGF, 
50 iig/ml). For the NGF withdrawal groups, medium containing NGF was removed 
and replaced with low-serum medium for the later period. Medium (土 NGF) were 
renewed every 2 days. At specific time points, images were captured and 100 cells 
were quantified for each well. Cells were considered as expressing neurite with 
neurite greater than one cell body in length. Results represent mean 士 S.E.M.，from 
six independent wells and two independent experiments. (Data analyzed with 
two-way ANOVA with Bonferroni post test. *P<0.05, ***P<0.001, compared with 
control group. ##P<0.01, ###iM).001, compared with NGF group.) 
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Fig. 3.28. The effect of ONO-AE3-240 on number of PC12 cells expressing 
neurites. P C 12 cells were maintained in low-serum medium (土 N G F , 50 ng/ml). 
ONO-AE3-240 (10"^ M) was added 5 h before the addition of NGF on Day 0. Drugs 
and medium were renewed every day. At specific time points, images were captured 
and 100 cells were quantified for each well. Cells were considered as expressing 
neurite with neurite greater than one cell body in length. Results represent mean 士 
S.E.M., from six independent wells and two independent experiments. 
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Fig. 3.29. The effect of ONO-AE3-240 on the length of neurites of PC12 cel!s. 
PC 12 cells were maintained in low-serum medium (士 NGF, 50 ng/ml). 
ONO-AE3-240 (10"' M) was added 3 h before the addition of NGF on Day 0. Drugs 
and medium were renewed every day. At specific time, images were captured and 
100 cells were quantified for each well. Cells were considered as expressing neurite 
with neurite greater than one cell body in length. Lengths of longest neurite of 
neurite-possessing cells were measured. Results represent mean ± S.E.M., from six 
independent wells and two independent experiments. 
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Fig. 3.30. The effect of ONO-AE3-240 on number of neurites expressed by PCI2 
cells. PC 12 cells were maintained in low-serum medium (士 NGF, 50 ng/ml). 
ONO-AE3-240 (10'^ M) was added 3 h before the addition of NGF on Day 0. Drugs 
and medium were renewed every day. At specific time, images were captured and 
100 cells were quantified for each well. Cells were considered as expressing neurite 
with neurite greater than one cell body in length. Results represent mean 士 S.E.M., 
from six independent wells and two independent experiments. (*P<0.05, **P<0.01, 
two-way ANOVA with Bonferroni post test.) 
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3.4 Adenosine Aia receptor activity in PCI 2 cells 
The activation of AC by forskolin is influenced by Gs proteins, which enhance 
AC activity when co-stimulated (Insel & Ostrom，2003). For example, in Sf9 cells, 
AC2, AC5 and AC6 were synergistically activated by forskolin and Gs (Sutkowski et 
al., 1994). Moreover, in PC 12 cells, endogenously produced adenosine also 
influenced the basal cAMP production as the treatment with adenosine deaminase 
\ 
(ADA), which metabolizes adenosine to inosine, or the presence of an A2a receptor 
antagonist, were found to decrease the basal cAMP production (Roskoski & 
Roskoski, 1989). 
In this part of the study, we aimed to explain the relationship between NGF and 
the enhanced forskolin-stimulated cAMP production by studying the involvement of 
A2a receptors in the regulation of AC activity in our PC 12 cells. Some reports 
suggested that NGF could down-regulate A2a receptor expression in PC 12 cells 
(Arslan et al., 1997; Nie et al., 1999). Therefore, w^ studied the effect of NGF on the 
A2a receptor response over 6 days, and also investigated the effect of blocking 八2八 
receptor activation on forskolin-stimulated responses in PC 12 cells. 
3.4.1 Effect of N G F on A i a receptor-mediated [^HjcAMP production 
The CGS21680-induced [^H]cAMP production of the control and NGF-treated 
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group were similar, having a gradual increase of response, except that there was an 
apparent decrease in the response of the control group on day 4 (Fig. 3.31). However, 
this finding appeared to contradict several studies showing that NGF could induce 
the down-regulation of A2A receptors, as revealed by the decrease of agonist-induced 
c AMP production and reduced amount of A2A receptor mRNA and protein expression 
(Arslan et a l , 1997; Nie et al., 1999). As NGF appeared not to regulate A2A receptors 
response in uur PC 12 cells, the removal of NGF also did not affect the A2A receptor 
response (Fig. 3.31). In contrast, for PC 12 cells with A2A receptor expression being 
down-regulated by NGF, the receptor expression was almost recovered completely 
after 2 days of NGF withdrawal (Nie et a l , 1999). 
To confirm that CGS21680 is really acting on A2A receptor in PC 12 cells, we 
have performed an antagonist study using the selective A2A receptor antagonist, 
ZM241385 (Uustare et a l , 2005). As expected, CGS21680 greatly increased the 
[^H]cAMP production in untreated PC12 cells (Fig. 3.32). ZM241385 did not affect 
the basal [^H]cAMP production, but strongly inhibited [^H]cAMP production 
induced by CGS21680 (Fig. 3.32). In summary, our results suggest that A2A receptors 
were expressed and NGF did not regulate A2A receptor-mediated [^HjcAMP 
production in our PC 12 cells. 
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3.4.2 Synergistic activation of adenylyl cyclase by A2A receptor and forskolin 
It has been demonstrated that the activation of AC by forskolin in 
undifferentiated PC 12 cells was greatly dependent on the presence of activated A2A 
receptors, as A2A receptor antagonists inhibited forskolin-stimulated cAMP 
production in a dose-dependent manner (Florio et al , 1999a). Conversely, adenosine 
which was applied exogenoiisly, could facilitate the forskolin-stimulated cAMP 
production in PC 12 cells (Florio et al., 1999a), which further highlighted the 
importance of the A2A receptor on the forskolin effect on AC. In our experiment, we 
aimed to investigate if NGF has any effect on the association of Aia receptor and 
forskolin on the activation of AC. 
In undifferentiated PC 12 cells, CGS21680 and forskolin were able to give about 
4- and 6-fold increase of [^HjcAMP production compared to the basal production, 
respectively (Fig. 3.33A). When the cells were treated with CGS21680 and forskolin 
simultaneously, [^H]cAMP production was enhanced in a synergistic manner, giving 
about 51-fold increase when compared to the basal production (Fig. 3.33A). A 
similar pattern was observed in NGF-treated cells, and the co-treatment with 
CGS21680 and forskolin increased [^H]cAMP production to a similar extent as in 
undifferentiated PC12 cells (Fig. 3.33B). 
The forskolin-induced [^H]cAMP production was also found to be sensitive to 
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ADA in PC 12 cells (Florio et a l , 1999b). Therefore, we have performed a 
preliminary experiment to test if the forskolin response was also sensitive to ADA in 
our PC 12 cells. In untreated PC 12 cells, ADA neither lowered the basal nor 
forskolin-stimulated [^H]cAMP production (Fig. 3.34). As a result, our PC 12 cells 
might not produce adenosine endogenously, or the endogenously produced adenosine 
might not play a significant role on the basal and forskolin-stimulated [^HjcAMP 
production in our PC12 cells. 
3.4.3 Chronic and acute effect of A D A and ZM241385 on [^H]cAMP 
production 
Since we have demonstrated that the exogenously applied A2a receptor agonist 
could enhance the activation of AC by forskolin in our PC 12 cells, and the forskolin 
response appeared not to be related to the endogenous production of adenosine as 
observed in the preliminary test in Fig. 3.34，we would like to further our study on 
how chronic or acute treatment with ADA or ZM241385 might affect the 
forskolin-stimulated [^H]cAMP production in untreated or NGF-treated PC 12 cells. 
The CGS21680 response was also measured in order to monitor the change of A2a 
receptor response which might be correlated with the forskolin response. 
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3.4.3.1 Chronic effect of A D A and ZM241385 
We study the chronic effect of ADA and ZM241385 in untreated or NGF-treated 
PC 12 cells on day 4，because the enhanced forskolin-stimulated [^H]cAMP 
production was first observed after 4 days NGF treatment. In untreated PC 12 cells 
incubated with ADA or ZM241385 for 4 days, neither ADA nor ZM241385 affected 
the basal [^H]cAMP production (Fig. 3.35A). Due to the variation of data, none of 
the forskolin or CGS21680 responses were classified as significant in control, 
ADA-treated or ZM241385-treated groups (Fig. 3.35A). Although ADA apparently 
enhanced the forskolin and CGS21680 response in untreated PC 12 cells, but these 
responses were not significantly different from those in control or ZM241385-treated 
group (Fig. 3.35A). 
In NGF-treated PC12 cells, neither ADA nor ZM241385 affected the basal 
[3h]cAMP production (Fig. 3.35B). Also, ADA or ZM241385 did not affect the 
forskolin-stimulated or CGS21680-induced [^HjcAMP production in NGF-treated 
cells (Fig. 3.35B). 
ADA would not inhibit the binding of CGS21680 to A2A receptors, so it was 
normal that chronic treatment with ADA would not affect the CGS21680-induced 
[^H]cAMP production in untreated and NGF-treated PC 12 cells. As the 
CGS21680-induced [^HJcAMP production reflected the 八2八 receptor expression in 
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PC 12 cells, it was necessary to remove all the ZM241385 before the addition of 
CGS21680. Our preliminary data showed that in untreated PC 12 cells incubated with 
ZM241385 for 2 days, the [^H]cAMP production of cells washed twice (the same 
procedure in all cAMP assay) before the addition of CGS21680 was comparable to 
that in Fig. 3.27 under the same conditions (Fig. 3.35). Also, the CGS21680-induced 
[^HjcAMP production of cells with four times washes was similar to cells with only 
twice washes (Fig. 3.36). Therefore, ZM24138^ was probably absent during the 
cAMP assay. As the CGS21680 responses in all the three treatment groups were 
comparable to each other, it suggested that ADA or ZM241385 were unlikely to 
affect A2a receptor responses (Fig. 3.35B). 
3.4.3.2 Acute effect of A D A and ZM241385 
In untreated PC12 cells, the preliminary data showed that ADA and ZM241385 
appeared not to affect the basal [^H]cAMP production, but seemed to increase the 
forskolin response slightly (Fig. 3.37A). The CGS21680 response was higher in 
ADA-treated group compared with control, while ZM241385 appeared to suppress 
the CGS21680-meidated [^H]cAMP production (Fig. 3.37A). 
In NGF-treated PC 12 cells, the basal [^H]cAMP production of control, 
ADA-treated or ZM241385-treated group were comparable to each other, while the 
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forskolin response was found to be higher in ADA- or ZM241385-treated groups 
(Fig. 3.37B). Similar as the findings obtained for the untreated PCI2 cells, in the 
presence of ZM241385, the CGS21680-meidated [^H]cAMP production was 
suppressed in NGF-treated PC 12 cells (Fig. 3.37B). 
As ZM241385 was present during the treatment with CGS21680, therefore, the 
CGS21680-induced [^HjcAMP production was suppressed in untreated and 
NGF-treated PC12 cells under acute treatment of ZM241385. Also, ADA did not 
affect the binding of CGS21680 to A2a receptors, therefore, acute treatment with 
ADA would not affect the CGS21680-indiiced [^H]cAMP production in untreated 
and NGF-treated PC 12 cells. However, it was unexpected that acute treatment with 
ADA or ZM241385 could increase forskolin-stimulated [^H]cAMP production in 
NGF-treated PC 12 cells, and it requires further study to clarify this point. 
3.4.4 Discussion 
In this part of study, we attempted to establish the relationship of 八2八 receptors 
in the enhanced forskolin-stimulated [^H]cAMP production in NGF-treated cells, 
although we did not get the complete picture, some of the findings were still 
noteworthy. We found that the 八2八 receptor was not regulated by NGF in our PC 12 
cells, instead of being down-regulated as observed from other research group (Arslan 
112 
et al., 1997; Nie et al., 1999), which raised the consideration that our PC 12 cells are 
not necessarily identical to others. Also, we confirmed the expression of A2a receptor 
in our PC12 cells as ZM241385 significantly inhibited the CGS21680-induced 
[^H]cAMP production, and the activation of Aja receptor by CGS21680 and 
forskolin could give a synergistic activation on AC. Although there were some 
evidences showing that the activation of AC by forskolin was strongly dependent on 
A2a receptor (Florio et al., 1999a; Florio et al , 1999b), the presence of activated A：a 
receptor appeared not to be a prerequisite for the functioning of forskolin on AC in 
our PC 12 cells. The enhanced forskolin-stimulated [^H]cAMP production in 
NGF-treated PC 12 cells on day 4 and day 6 was not related to the Aza receptor, as 
there was no significant difference of A2a receptor response between control and 
NGF-treated cells on day 4 and day 6. Also, in our preliminary study on the chronic 
and acute effect of ADA and ZM241385, there was no solid result showing that 
either ADA or ZM241385 could inhibit the forskolin response chronically or acutely. 
In conclusion, we found that the enhanced forskolin-stimulated [^H]cAMP 
production in NGF-treated cells (in section 3.2) was probably not due to the increase 
of A2a receptor expression after prolonged NGF treatment, which strengthen our 
hypothesis that NGF promote gene and protein expression of AC during 
differentiation and lead to the increase of forskolin-stimulated [^H]cAMP production. 
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Fig. 3.31. The effect of N G F on CGS21680-indiiced [^H|cAMP production by 
P C 12 cells. P C 12 cells were maintained in low-serum medium (士 N G F，50 ng/ml), 
and medium was renewed every 2 days. After pre-labelling with [^H]adenine, 
PC 12 cells were incubated with selective adenosine A2a receptor agonist, CGS21680 
(1 |iM) for 30 min. Results represent mean 士 S.E.M. of three independent 
experiments performed in duplicate. 
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Fig. 3.32. ZM241385 (Am receptor antagonist) blocked CGS21680-medlated 
[^HJcAMP production of PCI2 cells. PC 12 cells were maintained in low-serum 
medium for 2 days. After pre-labelling with [^HJadenine, PC 12 cells were 
pre-incLibated with HBS or ZM241385 (1 .uM) for 30 min. Then, cells were 
incubated with HBS or CGS21680 (1 },iM) for another 30 min. Results represent 
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Fig. 3.33. CGS21680 and forskolin work synergistically to increase [^H]cAMP 
production of PCI2 cells. P C 12 cells were maintained (A) in complete culture 
medium for 48 h or (B) treated with NGF for 32 h in low-serum medium. After 
pre-labelling with [^Hjadenine, PC 12 cells were incubated with HBS or CGS21680 
(1 |aM) alone, or in the presence of forskolin (1 ^M) for 30 min. Results represent 
mean 士 S.E.M. of three independent experiments performed in triplicate. (**P<0.01, 
***P<0.001, one-way ANOVA with BonfeiToni post test.) 
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Fig. 3.34. Adenosine deaminase ( A D A ) did not affect forskolin-stimulated 
[^HJcAMP production in PC12 cells. PC12 cells were maintained in low-serum 
medium for 2 days. After pre-labelling with [^HJadenine, PC 12 cells were 
pre-incubated with HBS or ADA (1 U/ml) for 30 min. Then, cells were incubated 
with HBS or forskolin (1 )liM) for another 30 min. Results represent mean 土 S.E.IvI., 
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Fig. 3.35. The chronic effect of adenosine deaminase ( A D A ) or ZM241385 on 
[^HJcAMP production of PC12 cells. PC12 cells were maintained in low-serum 
medium (A) in the absence (B) or presence of NGF for 4 days. ADA (1 U/ml) or 
ZM241385 (1 |iM) were added 3 h before the addition of NGF on Day 0. Then, 
drugs and medium were renewed on day 2. After pre-labelling with [^H]adenine, 
PC 12 cells were incubated with HBS, forskolin (1 pM) or CGS21680 (1 \iM) for 30 
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Fig. 3.36. Z M 2 4 1 3 8 5 was absent during c A M P assay of PC12 cells after chronic 
treatment. PC 12 cells were maintained in low-serum medium with ZM241385 (1 
|.iM) for 2 days. On the day of assay, cells were either washed with HBS twice or 
four times before incubated with CGS21680 (1 |iM) for 30 min. Results represent 
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Fig. 3.37. The acute effect of adenosine deaminase ( A D A ) or ZM241385 on 
[^HJcAMP production of PCI2 cells. P C 12 cells were maintained in low-serum 
medium (A) in the absence (B) or presence of NGF for 4 days. Drugs and medium 
were renewed on day 2. During the assay, cells were pre-treated with ADA (1 U/ml) 
or ZM241385 (1 |iM) for 30 min. Then, cells were incubated with HBS, forskolin (1 
|iM) or CGS21680 (1 |liM) for another 30 min. Results represent mean 士 S.D., from 
one experiment performed in duplicate. 
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Chapter 4 
Discussion and future perspectives 
4.1 Discussion 
The aim of this study was to examine the signal transduction pathways which 
are regulated by NGF during the early stages of neuronal differentiation using PC 12 
cells as the model system. The changes of cellular response and morphology of PC 12 
cells iiiduced by NGF will be discussed. 
The Gq-, Gs- or Gj- coupled prostanoid receptor expression in undifferentiated 
PC 12 cells cultured in complete culture medium or cells treated with 50 ng/ml NGF 
in low-serum medium for 32 h were characterized by measuring the effect of various 
prostanoid receptor agonists on [^H]IP or [^H]cAMP production after prelabelling 
with [^HJinositol or [^H]adenine, respectively. Undifferentiated PC 12 cells were 
unresponsive to all prostanoid receptor agonists tested for stimulation of PLC, 
revealed by the lack of stimulation in [^H]IP production, which indicated that there 
were no Gq-coupled prostanoid receptors expressed in undifferentiated PC 12 cells. 
Moreover, Gq-coupled prostanoid receptor expression was not induced by NGF in 
PC 12 cells, as observed by the lack of prostanoid receptor agonist-stimulated [^H]IP 
production in NGF-treated PC 12 cells. In contrast, the positive controls, bradykinin 
and ATP, significantly increased [^H]IP production in both undifferentiated and 
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NGF-treated PC 12 cells through the Gq-coupled B2 receptors and P2Y receptors, 
respectively. This result suggested that our experimental setup was feasible to detect 
[^H]IP production, and the lack of response to prostanoid receptor agonists was not 
due to the absence of Gq proteins. Although TP receptor mRNA has been reported to 
be expressed in PC 12 cells (Kitanaka et al., 1996), and the principal transduction of 
TP receptors was Gq, we found that the selective TP receptor agonist, U46619, did 
not stimulate [^H]IP production in either undifferentiated or NGF-treated PC 12 cells. 
There is no published data to suggest that TP receptors are functionally expressed in 
PC 12 cells, and the presence of mRNA of TP does not necessarily imply the 
translation to TP receptor protein. Therefore, oui findings are not contradictory to 
published literature as our PC 12 cells are not necessarily identical to others. In 
summary, there were no Gq-coupled prostanoid receptors expressed in PC 12 cells. 
In addition, we did not find Gs-coupled prostanoid receptors expressed in PC 12 
cells, as no stimulation in [^H]cAMP production was observed after treatment with 
various prostanoid receptor agonists. However, the failure for prostanoid receptor 
agonists to induce [^H]cAMP production in PC 12 cells was not due to the lack of Gs 
protein expression, because CGS21680 could significantly induce [^H]cAMP 
production in undifferentiated or NGF-treated PC 12 cells through the activation of 
Gs-coupled A2A receptors. The Gj-coupled EP3 receptors were expressed in 
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undifferentiated PC 12 cells, as three EP3 receptor agonists, PGE2, sulprostone and 
ONO-AE-248, could suppress forskolin-stimulated [^H]cAMP production, with 
P G E 2 having the highest potency. Also, PGE2 no longer suppressed 
forskolin-stimulated [^H]cAMP production in the presence of the EPS receptor 
antagonist, ONO-AE3-240, which further proved the expression of Gj-coupled EPS 
receptors in PC 12 cells. The inhibition on forskolin-stimulated [^H]cAMP production 
by the above EP3 receptor agonists appeared to be decreased after J2 h of NGF 
treatment, suggested that EP3 receptor expression might be down-regulated by NGF, 
however, we should not neglect the change of culturing condition from high- to 
low-serum state, which might also contribute to the change of EP3 receptor response. 
Although PGF2a significantly inhibited forskolin-stimulated [^HjcAMP production in 
undifferentiated PC 12 cells, it was unlikely for the cells to express Gj-coupled FP 
receptors as FP receptor mRNA was found to be absent from PC 12 cells (Kitanaka et 
al., 1996). Therefore, the PGF2a-induced response was probably due to the cross 
activation of EPS receptors (Narumiya et a l , 1999), as the PGF2a-induced response 
was decreased after NGF treatment, which follows the same pattern as the EP3 
receptor agonists-induced response. As a result, after a comprehensive study on the 
prostanoid receptor expression in PC 12 cells, we found that only EP3 receptors were 
expressed. However, we did not exclude the possibility that Gq- or Gs-coupled 
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prostanoid receptors might be expressed after NGF treatment longer than 32 h in 
PC12 cells. 
The time course effect of NGF on EP3 receptor response of PC 12 cells was 
studied. The change of EP3 receptor response over 6 days NGF treatment was 
determined by measuring the degree of PGE2-mediated inhibition of 
forskolin-stimulated [^HjcAMP production, which reflects the EP3 receptor 
expression in PC 12 cells. We found that no matter PC 12 cells were maintained in 
complete culture medium or low-serum medium, NGF appeared not to change the 
EP3 receptor response, but the forskolin-stimulated [^H]cAMP production was 
significantly enhanced after 4 days NGF treatment. When comparing the basal or 
forskolin-stimulated [^H]cAMP production between PC 12 cells maintained in high-
er low-serum condition, the responses for cells maintained in low-serum conditions 
was always lower than those in high-serum conditions. We speculated that the gene 
transcription responsible for cAMP production might be suppressed in low-serum 
conditions, so PC 12 cells maintained in low-serum condition will have a lower basal 
and forskolin-stimulated [^H]cAMP production. As a result, NGF did not influence 
the EPS receptor response of PC 12 cells over 6 days treatment, and the apparent 
down-regulation of EP3 receptor observed in section 3.1 was due to the transfer of 
cells from high- to low-serum condition. In order to confirmed that NGF really have 
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no effect on the regulation of EP3 receptor, it is better to perform radioligand 
receptor binding assay using [^H]PGE2, as this method can directly measuring the 
receptor expression level, but the cost of materials are much more expensive. It has 
been demonstrated that NGF increased COX-1 expression and endogenous PGE2 
production in PC 12 cells (Kaplan et al., 1997), however, indomethacin did not block 
the neurite outgrowth in PC12 cells (DeGeorge et al., 1988). Together with our 
findings showing thai NGF did not change the EP3 receptors expression in PC 12 
cells, the NGF-induced up-regulation of COX-1 and the subsequent production of 
prostanoids might have a paracrine instead of a autocrine role in PC 12 cells. 
NGF did not stimulate basal or enhance forskolin-stimulated [^HjcAMP 
production in untreated or NGF-treated PC 12 cells acutely, and the enhanced 
response to forskolin was maintained on day 6 when NGF was removed on day 4, 
but no persistent enhancement was observed at the later stage when NGF was 
removed on day 2’ therefore, these results suggest that the enhanced forskolin 
response was most likely due to the chronic effect of NGF on gene and protein 
expression. NGF activates TrkA by phosphorylation which peaks at 5 min, and 
chronic treatment with NGF did not change the level of total or phosphorylated TrkA 
receptor level during the differentiation of PC 12 cells (Chang et a l , 2003b). Also, 
exposure of NGF-treated cells after 7 days to an additional NGF treatment did not 
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further increase the degree of activation of TrkA (Chang et al., 2003b). As we did not 
observe an increase in basal or enhance forskolin-stimulated [^H]cAMP production 
in untreated or NGF-treated PC 12 cells after exposure to NGF for 30 min, the 
activation of TrkA was not directly related to the [^H]cAMP production. 
Among AC2, AC6 and ACS, only AC6 was detected in our PC 12 cells. However, 
the preliminary data showed that the AC6 expression was not up-regulated by NGF 
after 4 days or 6 days treatment, which did not match with the enhanced forskolin 
response observed on day 4 and day 6. Phosphorylation had been reported to inhibit 
the AC6 activity (Chem et al., 1995). Therefore, NGF might attenuate this inhibitory 
signal rather than up-regulate the AC6 expression to provide the enhanced forskolin 
response. Moreover, other AC isoforms might be responsible for the enhanced 
forskolin response in NGF-treated PC 12 cells, so it is necessary to characterize all 
the AC isoforms in PC 12 cells in order to establish the relationship between NGF 
and the enhanced forskolin-stimulated [^H]cAMP production. We speculated that the 
maintenance of AC level in PC 12 cells was NGF-independent at the later stage of 
differentiation, and if the elevation of cAMP production is directly related to 
differentiation, the change of cAMP production during the time course of NGF 
treatment should match with other differentiation markers, such as the expression of 
NfH and expression of neurites. 
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NGF is reported to promote the expression of NfH in PC 12 cells in a 
time-dependent manner (Liu et al., 2006). Our preliminary data did not show an 
obvious dose- or time-dependent relationship between NGF and level of NfH 
expression. The NfH level was slightly increased after 1 day NGF treatment and than 
maintained steady to day 4, which might suggest that differentiation of PC 12 cells 
was completed within 1 day NGF treatment. However, manual assessment or 
quantification of images of PC 12 cells showed that NGF increased the proportion of 
cells expressing neurites in a time-dependent manner, which implied that the NfH 
expression should also increase in a similar pattern. As we did not observe an 
increase of NfH expression in PC 12 cells exposed to NGF, it might be that our PC 12 
cells could express neurites independent of NfH or the experimental setup was not 
sensitive enough to detect the change of NfH expression. 
As we failed to use NfH expression as the marker of differentiation of PCI2 
cells, we employed a neurite assay to quantify the degree of differentiation. We found 
that NGF can promote differentiation of PC12 cells by increasing the proportion of 
neurite-expressing cells, length of neurite, and the average number of neurite 
expression, and all these parameters decreased when NGF was removed on day 2 or 
day 4. Although the enhanced forskolin-stimulated [^H]cAMP production was 
probably related to an increase of AC expression, which was maintained on day 6 
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when NGF was removed on day 4，this response was not enough or even not related 
to the maintenance of neurites. The cAMP analog, dibutyryl cAMP，has been 
reported to initiate neurite outgrowth by itself in PC 12 cells, or act synergistically 
with NGF to promote neurite outgrowth (Gunning et al., 1981b; Heidemann et al., 
1985; Hayakawa et a l , 1999). Unlike NGF, dibutyryl cAMP initiates neurite 
outgrowth independent of RNA synthesis, and the dibutyryl cAMP-induced neurite 
expression was not maintained when dibutyryl cAMP was replaced by NGF 
(Gunning et al., 1981b). The dibutyryl cAMP induced neurite outgrowth was quite 
rapid (response occurred after a few minutes), while NGF required several days to 
induce neurite in PC 12 cells (Heidemann et al., 1985). The rapid response of 
dibutyryl cAMP suggested that the neurite induced by dibutyryl cAMP was by 
reorganization of the existing materials for the cytoskeleton and was independent of 
new RNA or protein synthesis, while NGF induced neurite by new RNA and protein 
synthesis. The use of dibutyryl cAMP or cholera toxin, which increases cAMP level, 
could enhanced the NGF-induced differentiation in a synergistic manner in PC 12 
cells, revealed by the increase of neurite length and the proportion of cells with 
neurites (Gunning et al., 1981a; Heidemann et al., 1985), which suggested that 
cAMP and NGF induced neurite outgrowth through different mechanisms. Therefore, 
these published findings suggest that cAMP is involved in the initiation of neurite 
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outgrowth while NGF is required for the maintenance of neurites through the 
synthesis of RNA and protein and is independent of cAMP in PC 12 cells. 
Although ill PC 12 cells stably expressing EP3B receptor treated with EP3 
receptor agonist can induce neurite retraction through a PTX-insensitive but 
Rho-sensitive pathway (Katoh et al., 1996; Katoh et al., 1998a; Aoki et al., 1999)， 
either activation or blockade of EP3 receptors in our PC 12 cells did not influence the 
neurite expression. These results suggested that EP3 receptors might not directly 
regulate neurite outgrowth in PC 12 cells, or the strength of the signal of EP3 receptor 
response was not enough to trigger neurite retraction in non-transfected cells. The 
EF3 receptors might therefore not be essential for the development of the nervous 
system, because EP3 knockout mice are viable. However, EPS receptors are required 
for the proper functioning of the nervous system, as EP3 knockout mice lost their 
hyperalgesia response (Minama et al., 2001). 
In the final part of this study, we attempted to establish the relationship of 
Gs-coupled A2a receptors in the enhanced forskolin-stimulated [^H]cAMP production 
in NGF-treated cells, as activated Gs can enhance the activation of AC by forskolin 
(Insel & Ostrom, 2003), but we need to emphasis that most of the data came from 
preliminary studies only. We have proved that Aia receptors are expressed in PC 12 
cells, because the Aia receptor antagonist, ZM241385, could suppress [^H]cAMP 
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production induced by CGS21680, an 八2八 receptor agonist. Also, NGF did not 
regulate the A2A receptor expression, which suggested that A2A receptor was not 
directly related to the enhanced forskolin-stimulated [^HjcAMP production in 
NGF-treated PC12 cells. Moreover, co-stimulation of PC12 cells with CGS21680 
and forskolin did lead to a synergistic activation of AC, but forskolin-stimulated 
[^H]cAMP production was not suppressed by ADA, which might suggest that the 
activation of AC by forskolin was not dependent on any basal A2A receptor activity. 
In addition, our results did not clearly demonstrated that neither ADA or ZM241385 
treatment could inhibit forskolin-stimulated [^H]cAMP production in PC 12 cells, 
either acutely or chronically. As a result, the overall summary of this preliminary 
study is we have no solid findings suggest that A2A receptor activity is involved in 
forskolin-stimulated [^HJcAMP production in PC 12 cells. 
In conclusion, we have investigated the effect of NGF on the differentiation of 
PC 12 cells. We have demonstrated that NGF did not appear to regulate EP3 and A2A 
receptor expression, but the forskolin-stimulated [^H]cAMP production was 
enhanced at the later stage of differentiation possibly due to the up-regulation of AC 
expression during the differentiation process. The increase of AC expression was not 
involved in the maintenance of neurite expression, which suggested that other factors 
regulated by NGF participated in the differentiation of PC 12 cells. Perhaps this study 
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can provide valuable findings in order to understand the complex process of neuronal 
cell differentiation. 
4.2 Future perspectives 
NGF promoted differentiation of PC12 cells as revealed by the expression of 
neurites, however, NGF enhanced forskolin-stimulated [^H]cAMP production 
probably through the increase expression of AC, but this change is not directly 
related to the maintenance of neurites. We speculated that cAMP formation is 
involved in the initiation of neurite outgrowth but not required for their maintenance, 
although NGF did not significantly elevate the [Vi]cAMP production at early time 
point (e.g. from day 0 to day 2). Forskolin (stimulates AC directly) and pituitary 
adenylyl cyclase-activating peptide (stimulates AC through the activation of 
Gs-coupled PACl receptor) can stimulate neurite outgrowth in PC 12 cells (Vaudry et 
al., 2002; Hernandez et al., 1995). However, our co-investigators have demonstrated 
that the AC inhibitor, SQ22536, did not inhibit the neurite length of NGF-treated 
PC 12 cells after 2 days, suggesting that cAMP produced from tmAC is not the source 
for the NGF-induced initiation of neurite outgrowth. It is known that cAMP is 
produced from tmAC and sAC, therefore, it is a good approach to test if cAMP 
produced from sAC is also involved in the initiation of neurite outgrowth in PC 12 
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cells as it is activated by NGF (Stessin et al , 2006), using a selective sAC inhibitor, 
KH7 (Hess at al., 2005). If ICH7 can block the neurite outgrowth of PC 12 cells 
treated with NGF, then cAMP produced from sAC is the principal source involved in 
the initiation of neurite outgrowth. 
Although we have discussed that Gj-coupled FP receptors are unlikely to be 
expressed in PC 12 cells, and it is probably that PGF2a cross-activates Gj-coupled EP3 
receptors, it is still necessary to confirm this statement by determining the ability of 
PGF2a to inhibit forskolin-stimualted [^H]cAMP production in the presence of EP3 
receptors antagonist, ONO-AE3-240, or FP receptor antagonist, such as AL-8810 
(Sharif et al., 2001). If PGFza does not inhibit forskolin-stimulated ["^HJcAMP 
production in the presence ONO-AE3-240, then PGF2a is most probably 
cross-activates the Gj-coupled EP3 receptors in PC 12 cells. If PGF2a effect was not 
abolished by the presence of ONO-AE3-240, but abolished by AL-8810, then there 
are Gj-coupled FP receptors expressed in our PC 12 cells. 
Finally, we have to characterize all the nine AC isoforms in PC 12 cells, and 
study how NGF regulates their expression. We speculate that some of the AC 
isoforms will be up-regulated by NGF or the inhibitory signal on the AC activity will 
be suppressed, which lead to the enhanced forskolin-stimulated [^H]cAMP 
production in PC 12 cells. 
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